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Initial findings from whole exome sequencing of pediatric morphea lesional tissue
YE Chiu,1,2 BA Drolet,1,2 D Siegel1,2 and EA Worthey2,3 1 Dermatology, Medical College of 
Wisconsin, Milwaukee, WI, 2 Pediatrics, Medical College of Wisconsin, Milwaukee, WI and 
3 Human and Molecular Genetics Center, Medical College of Wisconsin, Milwaukee, WI
Morphea is a fibrosing disorder that causes significant morbidity through atrophy and fibrosis of the 
skin and underlying structures. The mechanism is believed to be autoimmune in nature, and it has 
been postulated that it is related to systemic sclerosis although the pathogenic pathways remain 
unknown. Linear morphea follows the lines of Blaschko, and somatic mutations have been found 
in several Blaschkoid disorders. We thus hypothesize that linear morphea is a mosaic condition 
caused by somatic alterations, perhaps in conjunction with germline factors that predispose to 
disease. Whole exome sequencing (WES) was performed on our discovery cohort of 3 pediatric 
subjects with linear morphea using DNA obtained from lesional tissue. WES was also performed 
on germline DNA from the proband, mother, and father. Analyses were performed according to 
methodologies developed for our clinical genomics lab and using CarpeNovo, our in house-de-
veloped software platform. Initially, we targeted 24 genes and 32 risk alleles previously associated 
with systemic sclerosis. We identified variants of interest in three systemic sclerosis-associated genes 
(MIF, PTPN22, and NLRP1), with variants present in one or more of the lesional DNA samples. 
Further analysis and validation of the preliminary WES results are underway.    
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The effect of laser radiation on expression of S100A8 and S100A9 genes in keratinocytes
A Lavrov,1 I Korsunskaya,1 A Melerzanov,2 E Petersen,2 M Minnibaev,1 V Sobolev,3 
A Soboleva2 and A Gersen1 1 RAS, Moscow, Russian Federation, 2 MIPT, Moscow, Russian 
Federation and 3 “UDL” Ltd., Moscow, Russian Federation
The aim of research was to examine the expression level of S100A8 and S100A9 genes on HaCaT cell 
line with the help of qPCR before and after low-intensity laser radiation resurfacing with wavelengths 
1,27 mkm, power 1-2 mW, frequency 80 Hz and exposure time in 1 and 5 minutes.The statistical 
significance was p<0,05.The expression of genes in 2 hours after laser radiation resurfacing with 
exposure for 1 minute was significantly increased in comparison with control samples. In 6 hours 
after laser exposition with duration time of 1 minute the expression of genes was increased in 24- and 
86-folds in comparison with control samples.After 24 hours the expression of genes was decreased 
significantly but it was still different from control samples (14- fold and 26-fold respectively).After 
laser exposition with exposure of 5 minutes the expression of genes was more increased than after 
exposure time of 1 minute.In 6 hours after the exposition the expression of genes was increased 
in 86-fold and 176-fold respectively.After 24 hours the expression level of genes was almost the 
same as in control samples, but was still increased in 2- and 3 folds respectively. The change of 
gene expression in keratinocytes correlates with the effect of intravenous blood irradiation with 
the same laser radiation properties in patients with psoriasis.In 2 to 3 days after the procedure the 
stimulation of the pathological process of the skin was shown (edema of the plaques,the appearance 
of new papules).After 3 to 4 procedures we observed the regression of the plaques and the remission 
expanded from 6 months to 1,5 years.The possible explanation of our results is that laser radiation 
was primarily absorbed by molecules of proteins,H2O,O2,carbon dioxide.They have become acti-
vated and took part in physical and physico-chemical interactions.It leads to increase of the Ca2+ 
concentration in intracellular matrix and activation of the Ca2+-depended processes,the main of 
them are cell membrane reparation and activation of proliferation.    
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Ichthyosis hystrix Lambert type and Curth–Macklin type are one entity with palms and soles 
unaffected (KRT10 mutation) / affected (KRT1 mutation)
W Wang,1 L Zhang,2 T Sun1 and L Li1 1 Dermatology, Peking University Third Hospital, 
Beijing, China and 2 Interventional and Vascular Surgery, Peking University Third Hospital, 
Beijing, China
Gene mutation underlies ichthyosis hystrix (IH) Lambert type is investigated and phenotype-geno-
type relation is reviewed by comparison with other IH types. IH Lambert type and Curth–Macklin 
type are very rare genetic skin diseases characterized by striking hyperkeratotic verrucous lesions. 
They can be well recognized from IH Brocq type (the most common IH type also named as epi-
dermolytic hyperkeratosis, erythrodermie congenitale ichthyosiforme type bulleuse) by no blister 
occurence clinically and perinuclear tonofilament shells formation ultrastructurally. Whether palms 
and/or soles are affected is a differential point between IH Curth–Macklin type and IH Lambert type. 
To now, there are 7 reports on IH Curth–Macklin type with 5 of them showing KRT1 gene mutation. 
Only 2 reports on IH Lambert type including the pedigree in this study. Exome sequencing, linkage 
and analysis and candidate genes sequencing were used. Three patients all carry the c.1304 TÇC 
missense mutation in KRT10 gene, causing p.Leu435Pro substitution (corresponding to 2B domain 
of K10 protein), which was not found in five unaffected individuals through three generations in 
this family and 100 ethnically matched healthy controls. Our results supported that IH Lambert 
type and Curth–Macklin type are one entity which could be divided into two categories of palms 
and soles unaffected/affected (NPS/PS), with KRT10 mutations causing NPS phenotype and KRT1 
mutations giving rise to PS phenotype, just like that in IH Brocq type.    
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Increased prevalence of headaches in PHACE syndrome
J Yu, BA Drolet and D Siegel Dermatology, Medical College of Wisconsin, Milwaukee, WI
PHACE syndrome is the association of large head and neck hemangiomas with posterior fossa brain 
malformations, hemangiomas, arterial anomalies, cardiac defects, aorta coarctation, and eye abnor-
malities. The most common extracutaneous features of PHACE are cerebrovascular abnormalities 
including narrowing and dysgenesis of major cerebral vessels, which has been estimated to be 
present in more than 90% of these patients. While the natural history of PHACE is largely unknown, 
debilitating headaches have been anecdotally reported as a late manifestation. These headaches 
are often under-treated due to poor understanding of its pathogenesis and fears of using vasoactive, 
migraine-abortive medications such as triptans which can raise the risk for acute ischemic strokes. 
In this study, we seek to estimate the prevalence of headaches and its unique clinical characteristics 
in PHACE. Given the high prevalence of cerebral vascular anomalies in these patients, we also 
seek to determine possible associations between headaches and abnormalities found on Magnetic 
Resonance Angiogram (MRA). We created and distributed a survey designed to assess the quality 
of headaches, prior treatments, and associated neurologic symptoms based on the International 
Classification of Headache Disorders II diagnostic criteria. All participants are a part of our PHACE 
Syndrome International Clinical Registry and Genetic Repository which has clinical information of 
over 175 patients with confirmed PHACE. Preliminary analysis of a subset of participants queried 
show that 62% of patients older than the age of 4 report debilitating headaches. A large majority of 
these patients also have MRA abnormalities. Comparatively, less than 20% of the normal children 
complain of headaches. From our results, we infer that children with PHACE have an unusually high 
prevalence of headaches compared to the general pediatric population and there is a possible link 
between intracerebral arteriopathies and headaches. This pilot study will enrich our understanding 
of the prevalence of headaches in PHACE patients and allow us to better predict at risk children.   
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Differential gene expression analysis in chronic cutaneous lupus reveals overlapping and 
distinct genetic elements between cutaneous and systemic disease
R Dey-Rao, JR Smith, S Chow and AA Sinha Dermatology, University at Buffalo, Buffalo, NY
Lupus Erythematosus (LE) is a remarkably heterogeneous autoimmune condition that can affect 
multiple organs, including the skin. There remain major gaps in knowledge regarding the genetic 
and molecular basis of this variability. The extent to which pathogenetic mechanisms are shared 
vs. distinct in cutaneous and systemic lupus erythematosus (CLE and SLE) has not been defined. To 
investigate these issues, we leveraged global gene expression data generated in our laboratory com-
paring lesional and non-lesional skin of chronic CLE (CCLE) patients. The lesional skin transcriptional 
signature in CCLE features prominent functional pathways that reflect an activated immune system, 
with enhanced inflammatory cytokine expression and activated neutrophils, as well as dysregulated 
apoptosis and complement cascade. We found a significant overlap of differentially expressed 
genes (DEGs) in CCLE with SLE gene expression data reported in the literature. Several previously 
reported SLE-associated susceptibility loci were also found to overlap with CCLE DEGs, including 
those mapping to CCLE “hot spots” that represent chromosomal regions harboring a statistically 
enhanced concentration of dysregulated transcripts. CCLE DEGs common with previously reported 
SLE-associated gene expression data and/or reported susceptibility loci highlight a central role for 
interferon and apoptosis in both cutaneous and systemic manifestations of the disease. Additionally, 
we identify chromosomal regions that may harbor distinct susceptibility loci for CCLE not previously 
associated with lupus. Our data indicate that both overlapping as well as distinct genetic factors 
underlie disease pathogenesis in systemic and cutaneous lupus. These findings have relevance to 
the diagnosis and clinical classification of disease and shed light on disease mechanisms.    
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Haploinsufficiency for a skin-specific isoform of SMARCAD1 causes autosomal dominant 
adermatoglyphia and perturbs the expression of epidermal differentiation-associated genes
J Nousbeck,1 O Sarig,1 L Magal,1 E Warshauer,1 B Burger,2 P Itin2 and E Sprecher1 1 Tel Aviv 
Medical Center, Tel Aviv, Israel and 2 University Hospital Basel, Basel, Switzerland
Autosomal dominant adermatoglyphia (ADG) is characterized by lack of palmoplantar epidermal 
ridges. Recently, ADG was found to be caused in one family by a mutation in SMARCAD1, a 
member of the SNF subfamily of the helicase protein superfamily. In the present study, using direct 
sequencing, we identified three additional heterozygous mutations in SMARCAD1 (c.378+2T>C, 
c.378+5G>C and c.378+1G>A) in a total of 6 patients. Surprisingly, all four ADG-causing mutations 
identified to date disrupt a single conserved donor splice site adjacent to the 3’ end of a non-coding 
exon and result in degradation of a skin-specific isoform of SMARCAD1. These data attribute to 
the SMARCAD1-skin specific isoform a pivotal role in dermatoglyph formation. In order to better 
understand the consequences of ADG-associated mutations, we compared the global transcription 
profile of primary keratinocytes down-regulated for SMARCAD1 and of patient-derived keratino-
cytes. A total of 9 genes were found to be differentially expressed in both patient and knocked down 
keratinocytes. Of interest, 7 of those genes have been implicated in epidermal ontogenesis and 
differentiation. In addition, these genes have been found to be associated with psoriasis, which is 
characterized by abnormal finger ridge patterns. The present data suggest that ADG is genetically 
homogeneous and result from perturbed expression of epidermal differentiation-associated genes.   
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Cole disease results from mutations in ENPP1
O Eytan,1 F Morice-Picard,2 O Sarig,1 J Nousbeck,1 K Ezzedine,2 O Isakov,3 Q Li,4 A Ishida-
Yamamoto,5 N Shomron,3 T Goldsmith,1 N Adir,6 J Uitto,4 SJ Orlow,7 A Taieb2 and 
E Sprecher1 1 Tel Aviv Medical Center, Tel Aviv, Israel, 2 Saint André Hospital, Bordeaux, 
France, 3 Tel Aviv University, Tel Aviv, Israel, 4 Thomas Jefferson University, Philadelphia, 
PA, 5 Asahikawa Medical University, Asahikawa, Japan, 6 Technion, Haifa, Israel and 7 New 
York University School of Medicine, New York, NY
Cole disease is a rare autosomal dominant genodermatosis featuring punctate keratoderma and 
patchy hypopigmentation. Using a combination of exome and direct sequencing, we showed 
complete co-segregation of the disease phenotype with 3 heterozygous mutations in ENPP1 in 3 
unrelated families. Surprisingly, mutations in ENPP1 were previously shown to underlie a number 
of recessive conditions characterized by ectopic mineralization including GACI and PXE. While 
ectopic calcification-associated mutations are distributed across the entire gene sequence, all muta-
tions causing Cole disease were found to affect cysteine residues within the somatomedin-B-like 
domain 2 (SMB2) of the protein. As this domain inhibits insulin signaling through binding of the IRS-1 
receptor, and insulin signaling is known to regulate keratinocyte proliferation and pigmentation, 
we assessed the effect of ENPP1 down-regulation on insulin signaling in primary keratinocytes. We 
found out that ENPP1 deficiency was associated with activation of the insulin signaling pathway as 
evidenced by a 1.5, 1.7 and 2.7-fold increase in IRS-1, AKT and ERK phosphorylation, respectively. 
Conversely, ENPP1 down-regulation was associated with decreased expression of various epidermal 
differentiation markers (including filaggrin, TGM1, involucrin and loricrin). Collectively, these results 
demonstrate a role for ENPP1 during epidermal proliferation in addition to its known function in 
the regulation of tissue mineralization.    
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Desmoglein 1 deficiency reveals a direct role for desmosomal dysfunction in allergic cuta-
neous reactions
L Samuelov,1 O Sarig,1 R Harmon,2 D Rapaport,3 E Warshauer,1 A Ishida-Yamamoto,4 
O Isakov,3 J Koetsier,2 R Bergman,5 S Peleg,6 C Goh,7 N Wilson,7 F Smith,7 E Pohler,7 
M Simpson,8 DF Murrell,9 J Salas,10 A Shani,6 A Paller,2 I McLean,7 A Irvine,11 M Horowitz,3 
J McGrath,8 K Green2 and E Sprecher1 1 Tel Aviv Medical Center, Tel Aviv, Israel, 2 
Northwestern University, Chicago, IL, 3 Tel Aviv University, Tel Aviv, Israel, 4 Asahikawa 
University, Asahikawa, Japan, 5 Rambam Hospital, Haifa, Israel, 6 Technion, Haifa, Israel, 7 
University of Dundee, Dundee, United Kingdom, 8 King College, London, United Kingdom, 
9 University of NSW, Sidney, NSW, Australia, 10 Universidad de Monterrey, Mexico, Mexico 
and 11 Trinity College, Dublin, Ireland
Recent studies suggest that desmosomal proteins may, in addition to their role in adhesion, also 
regulate pivotal intracellular processes. We investigated 12 patients with widespread Skin dermatitis, 
severe Allergies and Metabolic wasting (SAM syndrome), often associated with acantholysis. Using 
exome sequencing, we identified an in-frame deletion and a frameshift mutation in DSG1, encoding 
desmoglein 1, in 4 of these patients. Both mutations resulted in lack of incorporation of DSG1 into 
desmosomes. We previously showed that DSG1 promotes epidermal differentiation by inhibiting 
ERK through Erbin, which interacts with Shoc2 and disrupts Ras-Raf scaffolding. Accordingly, Erbin 
localization was aberrant in the skin of the patients, while pERK staining was increased, albeit to a 
lesser degree in the presence of the in-frame deletion, correlating with clinical outcome. Absence 
of DSG1 was found by Proximity Ligation Assay to result in increased Shoc2-Ras complexing. 
Moreover, using qRTPCR, IHC and ELISA, we found that down-regulation of DSG1 in human kera-
tinocytes is associated with overexpression of a wide array of cytokine genes (e.g. MCP-1, CCL22) 
and aberrant expression of all major differentiation markers. In summary, DSG1 deficiency results 
in: (1) acantholysis due to abnormal desmosome formation; (2) aberrant epidermal differentiation 
due to increased ERK activation; (3) cutaneous inflammation due to defective barrier and kerati-
nocyte secretion of pro-inflammatory mediators. These observations substantiate the notion that 
desmosomal function extends well beyond adhesion.    
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A novel mutation in TP63 causes a mild ectodermal dysplasia
T Goldsmith,1 L Magal,1 O Eytan,1 M Solomon,2 S Israeli,1 E Warshauer,1 M Grafi-Cohen,1 
D Aberdam,3 H van Bokhoven,4 H Zhou,4 O Sarig,1 E Sprecher1 and J Nousbeck1 1 Tel Aviv 
Medical Center, Tel Aviv, Israel, 2 Sheba Medical Center, Tel Hashomer, Israel, 3 University 
of Paris Diderot, Paris, France and 4 Radboud Medical Center, Nijmegen, Netherlands
Mutations in TP63, encoding the transcription factor p63, have been linked to various phenotypes. 
In the present study, we ascertained a large family featuring lower lip pits in addition to diastema, 
abnormal hair and nail, keratoderma and skin erythematous plaques. Because lower lip pits have 
been associated with mutations in IRF6, we excluded mutations in this gene and its enhancer. 
Instead, we identified a heterozygous mutation affecting a conserved residue of the p63 transcrip-
tion inhibitory domain. Using a reporter assay in both HeLa cells and primary keratinocytes, we 
showed that the mutation results in decreased p63 activity. Accordingly, transcription analysis of 
patient skin-derived cDNA revealed down-regulation of a number of known p63 targets, indicating 
a loss-of-function effect of the causative mutation. The present observations expand the spectrum 
of clinical manifestations associated with TP63 mutations.    
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Genome wide association study of psoriasis in India
RP Nair,1 LC Tsoi,1 M Ghosh,2 M Kabra,2 T Tejasvi,1 PE Stuart,1 MS Zawistowski,1 
JJ Voorhees,1 GR Abecasis,1 VK Sharma2 and JT Elder1,3 1 University of Michigan, Ann Arbor, 
MI, 2 All India Institute of Medical Sciences, New Delhi, India and 3 Ann Arbor Veterans 
Hospital, Ann Arbor, MI
Genome wide association studies (GWAS) have identified 36 psoriasis susceptibility loci (P < 5e-8) 
in European Caucasians and 12 in Chinese. Only 6 of the Chinese loci overlap with the Caucasian 
loci suggesting genetic heterogeneity. We report initial results of a GWAS of 953 psoriasis cases 
and 858 controls collected in New Delhi, India using 934,732 SNP markers. Principal component 
analysis showed that the samples are genetically similar to the HapMap Gujarati Indians in Houston 
samples. We tested for association by logistic regression after adjusting for the top 10 principal 
components. Multiple markers near HLA-C on chromosome 6 showed the strongest association 
with psoriasis. The top 16 associated markers are located 30-257 kb telomeric to HLA-C, with the 
most significant markers, rs1265181 and rs1265178 (OR = 5.3, P = 9.89e-54 for both), located 
81 kb and 75 kb telomeric respectively. In contrast, the most significantly associated markers map 
centromeric to HLA-C in Caucasian GWAS, and in Chinese GWAS, the top 9 associated markers 
map from 114 kb telomeric to 34 kb centromeric of HLA-C. Analysis of the genetic diversity 
underlying these differences may help pinpoint the psoriasis-predisposing genetic variation(s). In 
addition to the HLA-C region, two loci, one on chr12 and another on chr15, each had a single 
marker exceeding genome-wide significance. The GWAS also yielded six association signals with 
P < 1e-5. These include two markers in LAMB3 (chr1q32.2), one marker in KLHL29 (chr2p24.1), 
one marker on 2q11, one marker near ANXA6 (chr5q33.1), three markers near IL12B (5q33), and 
two markers near GPCPD1 (20p12.3). IL12B and ANXA6/TNIP1 are previously known psoriasis 
loci, and the other four are new. This first GWAS of psoriasis in a South Asian population shows 
strong evidence of association near HLA-C, and promising novel non-MHC signals meriting further 
study in a larger sample.    
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Mutations in SERPINB7, encoding a serine protease inhibitor, cause Nagashima-type pal-
moplantar keratosis
A Kubo,1 A Shiohama,1 T Sasaki,1 K Nakabayashi,2 J Kudoh,1 K Hata,2 A Umezawa,2 
Y Tokura,3 A Ishiko,4 H Niizeki,5 K Kabashima,6 Y Mitsuhashi7 and M Amagai1 1 Keio Univ, 
Tokyo, Japan, 2 National Research Institute for Child Health and Development, Tokyo, Japan, 
3 Hamamatsu Univ, Hamamatsu, Japan, 4 Toho Univ, Tokyo, Japan, 5 National Center for 
Child Health and Development, Tokyo, Japan, 6 Kyoto Univ, Kyoto, Japan and 7 Tokyo 
Medical Univ, Tokyo, Japan
Various endogenous and exogenous proteases exist in the skin. To maintain skin homeostasis and/
or protect skin from protease-induced damages, epidermis expresses various protease inhibitors. We 
recently identified that biallelic putative loss-of-function mutations in SERPINB7, which encodes 
a cytoplasmic member of the serine protease inhibitor superfamily, cause Nagashima-type palmo-
plantar keratosis (NPPK), an autosomal recessive PPK identified in Japan. We found that SERPINB7 
was specifically expressed in the cytoplasm of the stratum granulosum and the stratum corneum 
(SC) in healthy skin. In this study, we demonstrated that wildtype, but not mutants of SERPINB7 
identified in NPPK patients, inhibit the protease activity of plasmin in a dose dependent manner. 
Further expanded mutation analyses demonstrated bialleic mutations in SERPINB7 from 22/30 
patients of NPPK, but interestingly, 8/30 patients had only one heterozygous mutation in coding 
exons of SERPINB7 and showed relative milder disease phenotypes, suggesting these patients may 
have another downregulating mutation such as intronic mutations in SERPINB7 of the other allele. 
Cohort studies estimate the prevalence rate of NPPK as more than 1/10,000 in Asian populations, 
suggesting that NPPK is presumably the most common type of PPK in Asia despite of the fact that 
its disease entity was just recently recognized in international societies. When lesional skin was 
exposed to water, whitish spongy changes were observed in the SC, suggesting enhanced water 
permeation in the SC of NPPK. Thus, the identification of NPPK responsible gene as SERPINB7 
has provided a valuable tool, not only to understand the role of balance between proteases and 
protease inhibitors in the SC, but also to develop pathogenesis-based molecular therapies for NPPK.   
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Genome-wide approach to discover novel mouse models for cutaneous disorders
JP Sundberg,1,2 S Murray,1 J Eppig,1 KA Silva,1 VE Kennedy,1 D Begley,1 J Denegre,1 LE King,2 
PN Schofield3 and SS Dadras4 1 Department of Research and Development, The Jackson 
Laboratory, Bar Harbor, ME, 2 Division of Dermatology, Department of Medicine, Vanderbilt 
University, Nashville, TN, 3 Department of Physiology, Development, and Neuroscience, 
University of Cambridge, Cambridge, United Kingdom and 4 Departments of Dermatology, 
Genetics, and Developmental Biology, University of Connecticut, Farmington, CT
The development of genetically engineered mice (GEM), initially by inserting a DNA construct from 
a number of sources/species into a mouse (transgenesis) and later by targeted gene deletion, has 
revolutionized biomedical research. Until recently, GEM creation was mainly hypothesis-driven, 
one gene at a time, which can be labor intensive and expensive. To address this on a genome-wide 
scale, the International Knockout Mouse Consortium (IKMC) was formed to inactivate (“knockout”) 
all protein coding genes in the mouse genome in embryonic stem (ES) cells using several distinct 
well-defined targeting strategies. The Jackson Laboratory is one of three centers in the U.S. generating 
live mice from these ES cell lines (833 total through 2016). The resultant mutant mice are character-
ized as part of the International Mouse Phenotyping Consortium (IMPC) using a systematic in vivo 
physiological approach. Although the IMPC strategy may be appropriate to characterize abnormal 
phenotypes detected in a number of systems, the skin and its adnexa cannot be fully evaluated 
using exclusively in vivo observations. To ensure capturing fully the cutaneous pathophysiology in 
mutant mice, we integrated a histopathology-based approach and standardized the analysis using 
two females and two males as a primary screen with specific follow-up physiological assays based 
on the histopathological findings. Details of the protocols and images (standard digital and whole-
slide scanned images) are being placed on Mouse Genome Informatics (http://www.informatics.
jax.org/) and Pathbase (http://www.pathbase.net/) public access databases. Details on the protocols 
and summaries of analyses completed will be presented.    
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Deletion of mouse Col17a1 exon 50 results in a remarkably normal phenotype alone but 
greatly accelerates Lamc2jeb induced junctional epidermolysis bullosa
TJ Sproule,1 JP Sundberg,1 BE Low,1 EB Adkins,1,2 KA Silva,1 D Reyon,3,4,5 JK Joung,3,4,5 
MV Wiles1 and DC Roopenian1 1 The Jackson Laboratory, Bar Harbor, ME, 2 Sackler School 
of Graduate Biomedical Sciences, Tufts University, Boston, MA, 3 Molecular Pathology 
Unit, Massachusetts General Hospital, Charlestown, MA, 4 Center for Computational and 
Integrative Biology, Massachusetts General Hospital, Charlestown, MA and 5 Department of 
Pathology, Harvard Medical School, Boston, MA
We have shown previously that normal allelic variation in the collagen XVII non-collagenous 
domain 4 (NC4) encoded by Col17a1 exon 50 affects the onset and severity of Lamc2jeb induced 
junctional epidermolysis bullosa (JEB) in mice. Here we report on a mouse mutation resulting from 
transcription activator-like effector nuclease (TALEN) targeting of Col17a1 intron 50 which resulted 
in an in-frame deletion of all of exon 50 (Col17a1Δ567). Despite the apparent importance of NC4 to 
collagen XVII/laminin 332 binding, and the fact that many Col17a1 mutations can themselves result 
in JEB, mice homozygous for this deletion are surprisingly normal and free of disease. However 
greatly accelerated disease is seen in mice homozygous for the Lamc2jeb mutation when combined 
with the exon 50 deletion in either the heterozygous or homozygous state. This further demonstrates 
the epistatic interplay between epidermolysis bullosa disease causing alleles such as Lamc2jeb and 
relatively innocuous allelic variants such as Col17a1Δ567 which, when combined, greatly alter 
disease progression. It also highlights the surprising finding that removal of this relatively important 
and interactive region of the collagen XVII protein has little or no visible effect in the context of 
healthy alleles of Lamc2 and other basement membrane components.    
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Topically delivered nanoparticle-siRNA conjugates down-regulate GM3 synthase and reverse 
the impaired wound healing in diabetic mice
M Seeger, P Randeria, H Wilson, X Wang, CA Mirkin and AS Paller Dermatology and 
Chemistry, Northwestern Univ., Chicago and Evanston, IL
Chronic skin ulcers affect 15% of type 2 diabetes patients and often lead to amputation. We have 
previously shown that ganglioside GM3 accumulates in human diabetic foot skin and that knockout 
of GM3 synthase (GM3S) fully reverses the impaired wound healing of diet-induced obese (DIO) 
mice by activating insulin and IGF-1 receptors. We have now developed a novel siRNA delivery 
system in which siRNAs densely surround a gold nanoparticle (spherical nucleic acid; SNA). After 
topical delivery SNAs penetrate the epidermal barrier of intact mouse and human epidermis and 
show superb cell uptake, increased stability, and no cutaneous immunoreactivity. We hypothe-
sized that knockdown of GM3S by topically delivered SNAs would accelerate healing in diabetic 
mouse wounds. GM3S siRNA SNAs were chosen that knocked down GM3S and depleted GM3 
in both mouse keratinocytes (by 82%) and human keratinocytes (NHEKs) (by 72%). Treatment of 
NHEKs with 250 pM GM3S siRNA SNA for 72 h: i) increased cell proliferation at 4 days by 1.3-
fold under normoglycemic conditions and 4.5-fold under hyperglycemic conditions; ii) increased 
NHEK migration in scratch assays by 1.6-fold in standard medium; and iii) further accelerated NHEK 
migration in medium with excess glucose. 50 nM GM3S siRNA SNA in Aquaphor® vehicle, applied 
topically every other day, knocked down GM3S by >80% in intact and wound edge skin by day 
8. GM3S siRNA SNAs accelerated healing of full-thickness splinted back wounds in DIO diabetic 
mice in comparison with free GM3S siRNA, scrambled siRNA SNAs, and vehicle controls (p<0.001 
by 4 and 8 days). By 12 days, GM3S siRNA SNA-treated wounds were fully healed clinically and 
histologically, whereas control-treated wounds showed an epidermal gap >60% of baseline. BrdU 
labelling of basal keratinocytes was also increased in GM3S siRNA SNA-treated wounds. These 
data further implicate GM3 in mediating delayed wound healing in diabetes and support depletion 
of GM3 by topically applied GM3S siRNA SNAs as a new therapeutic direction.    
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A meta-analysis of genome-wide association studies identifies novel loci associated with 
bullous pemphigoid in Han Chinese population
J Gao,1,2,3 Y Sheng,1,2,3 Y Li,1,2,3 Y Cui,1,2,3 L Sun,1,2,3 S Yang1,2,3 and X Zhang1,2,4 1 Department 
of Dermatology and Venerology at No.1 Hospital, Hefei, China, 2 Key Laboratory of 
Dermatology, Anhui Medical University, Ministry of Education, China, Hefei, China, 
3 Institute of Dermatology, Anhui Medical University, Hefei, China and 4 Institute of 
Dermatology, Huashan Hospital of Fudan University, Shanghai, China
ABSTRACT Bullous pemphigoid (BP) is a chronic autoimmune blistering disease characterized by 
subepidermal blistering. The onset and course of BP depend on a variable interaction between 
predisposing and inducing factors. A number of candidate genes studies conducted in various 
populations have revealed associations between BP and HLA class II regions. The prevalence of BP 
is very low in worldwide that represents a significant obstacle to perform genome wide approach 
to explore susceptibility genes. In order to investigate the genetic architecture underlying BP and to 
reduce spurious results due to population genetic structure, we performed a meta-analysis of two 
genome-wide association studies cohorts in total of 292 BP cases and 1566 controls from southern 
and northern of Han Chinese populations. We identified a new susceptibility locus at 1q43 (P = 
6.38×10-9, OR = 3.14) significantly associated with BP and two suggestive loci located at 18q21.31 
(P =1.38×10-7, OR = 2.51) and 2p25.3 (P = 1.96×10-7, OR = 2.52). We also confirmed previously 
reported the HLA class II gene for BP and detected one significant risk haplotype CGGG from the 4 
SNPs at 6p21 (P = 3.29×10-8, OR = 1.92). The most significant genetic variants at 1q43 indicated 
a gene, which involved in inflammatory responses and immune receptor signaling. These findings 
will be promoting us to deeply understand the genetic bases and highlight the role of genetic variants 
of non-MHC region in mechanism of BP.    
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The common variants shared between schizophrenia and psoriasis in Han Chinese population
X Yin,1,2,3 N Wineinger,4,6 S Yang,1,2,3 NJ Schork4,5,6 and X Zhang1,2,3 1 Institute of 
Dermatology, Anhui Medical University, Hefei, China, 2 Department of Dermatology, The 
First Affiliated Hospital, Anhui Medical University, Hefei, China, 3 Key Lab of Dermatology, 
Anhui Medical University, Hefei, China, 4 The Scripps Translational Science Institute, The 
Scripps Research Institute, San Diego, CA, 5 Department of Molecular and Experimental 
Medicine, The Scripps Research Institute, La Jolla, CA and 6 Scripps Health, La Jolla, CA
To explore the potential overlap of susceptibility between psoriasis and schizophrenia, we applied 
the mixed linear model and found that 21% co-heritability (s.e.=0.20, P(rg SNP =1)=0.009) existing 
between psoriasis and schizophrenia in 3560 samples. We estimated that > 85% (h2 =29%, s.e. = 
0.05, P = 2.00 ×10-8) of this sharing heritability captured by common variants in our samples, sug-
gesting that many common variants are shared across psoriasis and schizophrenia. In the combined 
sample, we identified at least 5 susceptible signals taking responsible of the sharing susceptibility 
within HLA region for psoriasis and schizophrenia (Passociation < 5.00×10-8) through building 
LASSO model and multivariate analyses. Our results showed that these 5 SNPs exerted the combined 
risk effect. We provided the significant evidences of sharing biological process between psoriasis 
and schizophrenia through gene ontology association test. Our results imply that the overlapped 
heritability takes effect possible through antigen processing and endoplasmic reticulum system. We 
highlight the important role of immune and calcium signaling in their pathology.    
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Correction of structural defect of the hair shaft through allele-specific silencing of a dominant 
mutant form of Krt75
Y Liu,1,2,4 L Zhang,1,2 DR Roop,3 C Qin1,2 and J Chen2,3,4 1 Key Laboratory of Human Disease 
Comparative Medicine, Ministry of Health, Beijing, China, 2 Institute of Laboratory Animal 
Science, Chinese Academy of Medical Science (CAMS) & Comparative Medical Center, 
Peking Union Medical College (PUMC), Beijing, China, 3 Department of Dermatology and 
Gates Center for Regenerative Medicine and Stem Cell Biology, University of Colorado 
Anschutz Medical Campus, Aurora, CO and 4 Departments of Pathology and Dermatology, 
Stony Brook University, Stony Brook, NY
Dominant mutations in keratin genes cause a number of inheritable skin disorders, characterized by 
intraepidermal blistering, hyperkeratosis, thickening of the nail plate, and defects in hair formation. 
Allele-specific silencing of mutant keratins has been shown to be an effective therapeutic approach 
for suppressing the epidermal phenotypes, yet, the correction of the nail and hair phenotypes remains 
unexplored. In this study, we engineered mutant-specific siRNAs to suppress the expression of a 
mutant form of Krt75, with an aim to correct the hair shaft blebbing phenotype in vivo. Two siRNA 
oligos were able to selectively suppress the expression of the mutant Krt75 as demonstrated by 
transient transfection in vitro. Subsequently, shRNAs were cloned into lentiviral vectors, and used 
to infect epidermal keratinocyte stem cells isolated from mutant Krt75 mice harboring the same 
mutation. Infected keratinocyte stem cells were used to reconstitute hair follicles in vivo by grafting. 
We demonstrated that the mutant-specific shRNA was able to suppress the formation of phenotypic 
hair shafts. Specifically, the proportion of phenotypic hair shafts formed by control shRNA treated 
cells was significantly reduced from 29.73% ± 10.23% to 4.57% ± 2.58% in mutant-specific shRNA 
treated cells. Furthermore, this phenotypic correction was concomitant with significant reduction 
of the expression of the mutant Krt75 mRNA in the skin grafts. This study demonstrated the feasi-
bility of correcting structural abnormalities of skin appendages, specifically the hair shaft, through 
shRNA-mediated allele-specific silencing of mutant keratins.    
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Genetic basis of pseudoxanthoma elasticum: The Chinese mutation profile in ABCC6 and 
ENPP1 genes
Q Jiang,1 ZS Wu,2 L Jin,2 CX Shao,1 Y Zhou,1 J Uitto1 and G Wang2 1 Dermatology and 
Cutaneous Biology, Jefferson Medical College, Philadelphia, PA and 2 Dermatology, Xijing 
Hospital, Fourth Military Medical University, Xi, China
Pseudoxanthoma elasticum (PXE) is an autosomal recessive disorder characterized by mineralization 
of elastic fibers in dermal, ocular and arterial tissues. The classic PXE is caused by mutations in 
the ABCC6 gene, which encodes a transmembrane efflux transporter primarily expressed in the 
plasma membrane of hepatocytes. The genesis of PXE is complicated by phenotypic and genotypic 
heterogeneity. In this study, we investigated 22 Chinese PXE patients from unrelated families, hith-
erto the largest cohort of Chinese PXE patients. We sequenced the complete ABCC6 and another 
potential causative gene, ENPP1, followed by pathogenicity analyses for each variant. We identified 
4 novel frame shift and 10 novel missense mutations in ABCC6. In addition, one novel missense 
mutation in ENPP1 was discovered in a pediatric PXE case. Among all identified mutations, only 
two have been reported previously in Caucasian population. The mutation detection rate among 
all alleles was 84.1%. Using an in vivo transient expression system, all 10 missense mutations were 
expressed in mouse liver via hydrodynamic tail vein injections. One mutant protein, p.L605P, 
showed intracellular accumulation indicating abnormal trafficking, while the other 9 mutants 
showed plasma membrane location in hepatocytes. These 9 mutations were further investigated 
for their pathogenicity using a recently developed zebrafish mRNA rescue assay. Minimal rescue 
of the morpholino-induced phenotype was achieved with several mutant human ABCC6 mRNAs, 
such as carrying p.L948P mutation, while partial rescue was observed with mRNA carrying p.R64Q 
mutation. This study demonstrates that the Chinese PXE population harbors unique mutations, and 
these genetic data have implications for elucidation of the pathogenesis as well as allele-specific 
therapy for selected patients with PXE.    
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Bone abnormalities in trichothiodystrophy: Central osteosclerosis is a prognostic marker for 
increased risk of early death
AB Barsell,1,2 R Allawh,1,2 M Xiong,1,3 D Tamura,1 M Collins,5 SM Steinberg,6 SG Khan,1 
S Hill,4 KH Kraemer1 and JJ DiGiovanna1 1 Derm Br, NCI, Bethesda, MD, 2 George Wash 
Univ School of Med, Washington, DC, 3 Brown Univ School of Med, Providence, RI, 4 
Radiology, NIH, Bethesda, MD, 5 NICDR, Bethesda, MD and 6 Biostatistics, NCI, Bethesda, 
MD
Trichothiodystrophy (TTD) is a rare autosomal recessive multisystem disorder with a wide variety 
of clinical findings with defects in DNA repair/transcription genes XPD, XPB, TTDA or in TTDN1. 
We followed a cohort of 32 patients with TTD from 2001 to 2013. Their age ranged from 0.75 to 
29 yr (mean 8.3 yr) and mean length of follow-up was 2.6 yr. All patients had diagnostic “tiger tail” 
banding of their hair on polarized microscopy. Other abnormalities included low birth weight, short 
stature, microcephaly, dysmyelination of the brain, congenital cataracts, photosensitivity, ichthyosis 
and sulfur-deficient brittle hair.There was a high frequency (81%) of bone abnormalities found. 
The most common abnormalities seen on bone imaging studies were central osteosclerosis (55%), 
peripheral osteopenia (35%), hip abnormalities (16%), generalized osteopenia (13%) and delayed 
bone age (13%). Five patients with hip abnormalities had severe progressive walking impairment. 
We found that XPD mutations and having a height and weight below the third percentile were 
significantly related to the presence of central osteosclerosis (P<0.001; P<0.001). TTD patients 
with radiographic evidence of central osteosclerosis of the skeleton had a poor clinical prognosis. 
Eight patients died (median age 8 yr) and 7 of these had central osteosclerosis. By ages 10-20 
years, TTD patients with central osteosclerosis had a higher (45-60 fold) risk of death as compared 
to the general US population. Bone abnormalities are a common finding in TTD. Hip involvement 
may predict impaired ambulation and central osteosclerosis may be a marker for early mortality.   
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Novel mouse models for pseudoxanthoma elasticum: Genetic and dietary modulation of the 
ectopic mineralization phenotypes
Q Li,1 H Guo,1 D Chou,1 A Berndt,2 JP Sundberg3 and J Uitto1 1 Jefferson Medical College, 
Philadelphia, PA, 2 University of Pittsburgh, Pittsburgh, PA and 3 The Jackson Laboratory, 
Bar Harbor, ME
Pseudoxanthoma elasticum (PXE), a heritable ectopic mineralization disorder caused by mutations 
in the ABCC6 gene, shows considerable intra- and interfamilial heterogeneity. Null mice (Abcc6-/-) 
recapitulate the genetic, histopathologic and ultrastructural features of PXE, and they demonstrate 
early and progressive mineralization of vibrissae dermal sheath, which serves as a reliable biomarker 
of the progression of overall mineralization processes affecting the internal organs, primarily the 
arterial blood vessels. Recently, as part of a mouse aging study at The Jackson Laboratory, 31 
inbred mouse strains were necropsied, and two of them, KK/HlJ and 129S1/SvImJ, were noted to 
have vibrissae dermal sheath mineralization similar to Abcc6-/- mice. These two strains were shown 
to harbor a single nucleotide polymorphism (rs32756904) in the Abcc6 gene, which resulted in 
out-of-frame splicing and marked reduction in ABCC6 protein expression in the liver, as judged by 
immunohistochemistry and Western analysis. The same polymorphism is present in two additional 
mouse strains, DBA/2J and C3H/HeJ, with similar reduction in ABCC6 protein levels, yet these mice 
did not demonstrate tissue mineralization when kept on standard rodent diet. However, all four 
mouse strains, when placed on experimental diet enriched in phosphate and low in magnesium, 
developed extensive ectopic mineralization. These results indicate that the genetic background of 
mice and the mineral composition of their diet can profoundly modulate the ectopic mineralization 
process predicated on mutations in the Abcc6 gene. These mice provide novel model systems to 
study the pathomechanisms and the reasons for phenotypic variability in PXE.    
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Phase I clinical trial of genetically corrected autologous epidermal keratinocytes for recessive 
dystrophic epidermolysis bullosa
Z Siprashvili,1 NT Nguyen,1 E Gorell,1 P Khuu,1 L Furukawa,1 HP Lorenz,1 TH Leung,1 
DR Keene,2 P Khavari,1,3 M Marinkovich1,3 and AT Lane1 1 Stanford University, Stanford, CA, 
2 Shriners Hospital for Crippled Children, Portland, OR and 3 VA Palo Alto, Stanford, CA
Recessive Dystrophic Epidermolysis Bullosa (RDEB) is an inherited genetic blistering skin disorder 
caused by mutations in the COL7A1 gene. Despite advances in the molecular diagnosis of this 
disease, current therapy is limited to supportive palliation. In previous studies we have shown that 
epidermis regenerated from retrovirally transduced autologous keratinocytes (KC) allows long-term 
restoration of type VII collagen (C7) to human EB skin transplanted onto an immunodeficient mouse. 
This preclinical study of ex vivo gene therapy approach served as the basis to initiate phase I clin-
ical trial for the treatment of severe RDEB. The first subject enrolled into this trial is a 23 year old 
male affected by RDEB. He is a double heterozygous carrier of p.C31AfsX73 and p.N1684KfsX13 
mutations with truncated C7 expression undetectable by NC2 C7 antibodies and sparse rudimen-
tary anchoring fibrils by electron microscopy (EM). Autologous KC were transduced with GMP 
grade retrovirus carrying the full-length COL7A1. Six ~35cm2 autologous epidermal sheet grafts 
were manufactured and grafted on to prepared wound beds on the bilateral upper extremities. We 
observed complete epidermal regeneration 30 days post grafting with clinically normal skin appear-
ance and no signs of immunological rejection. The regenerated epidermis was non-pruritic and 
did not form blisters. Molecular analysis of the skin biopsy obtained from the grafted site revealed 
robust C7 expression at the dermal-epidermal junction, detected by NC1 and NC2 antibodies, with 
morphologically normal appearance and frequency of NC2 reactive anchoring fibrils detected at 
the basement membrane zone using EM and immuno-EM techniques. These data indicate that 
genetically engineered primary autologous KC are capable of cutaneous type VII collagen delivery 
highlighting the potential of durable cell based RDEB therapy in humans.    
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A novel trinucleotide deletion in 2B domain of KRT10 presents with a mild epidermolytic 
ichthyosis phenotype
H Mirza,1 B Craiglow,1 J Zhou,1 C Saraceni,1 B Ragsdale,3 R Torbeck,4 LM Milstone,1 
P Rehder5 and KA Choate1,2 1 Dermatology, Yale University, New Haven, CT, 2 Pathology, 
Yale University, New Haven, CT, 3 Central Coast Pathology Laboratory, San Louis, CA, 4 
St Luke’s Hospital, New York, NY and 5 The Dermatology Medical Group, Camarillo, CA
Autosomal dominant missense mutations in the highly conserved rod domains of KRT1 and KRT10 
cause epidermolytic ichthyosis (EI) which is characterized by generalized erythroderma and blister-
ing at birth with hyperkeratosis later in life. In the present study we describe two unrelated kindreds 
presenting with a mild EI phenotype. In both kindreds, the index case was born with normal, intact 
skin, and by age 2, each developed scaling and corrugated hyperkeratosis at sites of skin friction 
without blisters or skin fragility. Skin biopsy showed acanthosis and hyperkeratosis without the 
significant epidermolysis pathognomonic of EI. Genomic sequencing of KRT10 in the index case of 
each kindred demonstrated an identical heterozygous trinucleotide deletion c.1301_1303delAAC 
which leads to deletion of the highly conserved glutamine residue in the KRT10 2B rod domain 
(p.Q434del). This mutation was not found in 1500 ethnically-matched control individuals. Since 
missense mutations in KRT10 which cause EI disrupt the intermediate filament (IF) network and 
cause formation of cytoplasmic IF clumps and pyknosis, we performed immunolocalization studies 
in patient skin and HaCaT cells transfected with KRT10 constructs. Patient skin showed reduced 
KRT10 expression with perinuclear accentuation, suggestive of IF collapse. There was ectopic 
expression of KRT6 throughout the epidermis as is seen in other hyperproliferative skin disorders. 
When p.Q434del mutant KRT10 was expressed in HaCaT cells it integrated into the pre-existing 
IF network causing a perinuclear collapse without induction of pyknosis or IF clumping seen with 
typical EI missense mutations. We propose that the observed lack of skin fragility in subjects with 
the p.Q434del mutation represents distinct phenotype from typical EI missense mutations in which 
IF clumping induces a cellular stress response.    
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Mutations in TTDN1 are associated with a unique trichothiodystrophy phenotype
ER Heller, SG Khan, D Tamura, JJ DiGiovanna and KH Kraemer Derm Br, NCI, Bethesda, MD
We followed a cohort of 36 patients with trichothiodystrophy (TTD), a rare autosomal recessive 
disorder, from 2001 to 2013. All the TTD patients have “tiger tail” banding of their hair with 
polarized microscopy along with a spectrum of multi-system abnormalities. The majority of TTD 
patients have mutations in nucleotide excision repair genes: XPD, XPB or TTDA. While most TTD 
patients are photosensitive, patients with mutations in TTDN1 (C7ORF11), a gene of unknown 
function, were reported by others to be non-photosensitive. We now describe 5 TTD patients (age 
1 to 14 yrs) from 4 families with defects in the TTDN1 gene: 4 had no photosensitivity (TTD402BE, 
TTD480BE, and siblings TTD487BE and TTD488BE) and 1 had photosensitivity (TTD343BE). DNA 
sequencing revealed 2 heterozygous initiation codon mutations in TTD402BE, heterozygous single 
base deletions in TTD480BE and in the two siblings, and as in the earlier report, large deletions in 
the TTDN1 gene in all the other alleles. Careful clinical examination revealed phenotypic differences 
between the patients with TTDN1 mutations and the 31 other TTD patients in our cohort. Delayed 
bone age was overrepresented in the TTDN1 group (p=0.009). A happy, outgoing and socially 
interactive personality is a characteristic TTD feature. In contrast, the two oldest TTDN1 patients 
had autistic features with difficulties in social interaction and repetitive behaviors (p=0.037). Unlike 
the other TTD patients, the TTDN1 patients did not have laboratory abnormalities of low MCV 
(p=0.013), elevated hemoglobin A2 (p=0.004), osteosclerosis of the central skeleton (p=0.045), or 
dysmyelination on brain MRI (p=0.029). Their height and weight was not reduced and they did not 
have neonatal findings (low birth weight, collodian membrane, congenital cataracts) frequently 
seen in the other patients but these differences were not statistically significant. In addition to the 
difference in mutation type (deletions), these data identify a unique phenotype relationship in TTD 
caused by TTDN1 and suggest a different mechanism of disease.    
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The role of core clock gene bmal1 in propionibacterium acnes-induced inflammation in 
sebocytes
J Nobe,1 M Qin,1 A Park,1 HJ Garban1 and J Kim1,2 1 Department of Medicine, Division of 
Dermatology, David Geffen School of Medicine at UCLA, Los Angeles, CA and 2 Department 
of Dermatology, Greater Los Angeles Healthcare System Veterans Affairs, Los Angeles, CA
Circadian rhythms underlie many aspects of immune function, for example, the oscillation of cyto-
kine secretion from monocytes. Recent studies demonstrate the importance of circadian rhythms in 
skin, yet few studies have investigated the circadian clock’s role in skin immune function. Sebocytes 
are integral components of the pilosebaceous unit that are involved in the skin’s inflammatory 
response to Propionibacterium acnes, the bacterium implicated in the pathogenesis of acne vulgaris. 
In our study, we aim to characterize the role of clock genes in sebocyte immune function using an 
immortalized human sebocyte cell line (SEB-1). We demonstrate that P. acnes at a multiplicity of 
infection of 10 induces a thirteen-fold increase of IL6 gene expression and three-fold increase of IL-6 
secretion (p<0.05) in SEB-1 sebocytes. Brain and muscle Arnt-like protein-1 (BMAL1), also known as 
ARNTL, is an important transcription factor of the mammalian molecular clock that has been shown 
to regulate innate immune responses in other organ systems. When Bmal1 is disrupted using small 
interfering RNA, we find a two-fold increase in IL6 expression in SEB-1 sebocytes (p<0.05). As we 
show that P. acnes induces activation of NF-κΒ p65 in SEB-1 sebocytes, Bmal1 regulation of IL-6 
may possibly involve the NF-κΒ p65 pathway as well. Here we demonstrate that the circadian clock 
is involved in the inflammatory response of sebocytes to P. acnes. These results may help broaden 
our understanding of the role sebocytes play in acne pathogenesis and provide an opportunity to 
consider diurnal regimen for treatment.    
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Transcriptonal analysis of androgenetic alopecia provides insights into the genetic basis of 
disease
A Gor, R Dey-Rao and AA Sinha Dermatology, University at Buffalo, Buffalo, NY
We employed genome wide microarray analysis to determine transcriptomal profiles in androgenetic 
alopecia (AGA). This data was used to functionally annotate pathways that may be important to 
AGA pathogenesis and shed light on potential genetic risk factors. A gene signature comprised of 
434 differentially expressed genes (DEGs) was generated comparing 3 lesional and 3 site-matched 
control samples using the Affymetrix Human Genome U95A microarray platforms. Hierarchical 
clustering based on the obtained gene signature separated the samples into their corresponding 
phenotype. Functional annotation and pathway analysis identified multiple dysregulated pathways, 
including those involved in Wnt signaling, TGFβ signaling, and apoptosis. AGA-associated DEGs 
were mapped to previously reported AGA susceptibility loci including 1p36, 2q35, 2q37, 3q21-
q29, 12p12, 17q21, 18q11-q23, 19p13-q13, 20p11. Our analysis also revealed transcriptional 
“hot spots” (harboring statistically higher numbers of DEGs than would be expected by chance) 
on 1q21, 2p13, 4q24-25, 11p14.3-15.4, 14q11.1-11.2, 14q32, 15q21-22.2, 19q13, 20q12-q13.1, 
Xq22-25, which help to confirm and suggest novel disease susceptibility loci/regions. By integrating 
genomic information with transcriptional data, our study reveals potential susceptibility loci/regions 
associated with androgenetic alopecia in terms of altered gene expression. Detailed characteriza-
tion of the genetic and transcriptional alterations associated with AGA development may facilitate 
the development of novel therapeutic modalities focused on individualized and specific targets.   
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Identification of the promoter region in human IL-33 gene, and analysis of its regulation in 
keratinocytes, endothelial cells and fibroblasts
H Tsuda,1 M Komine,1,2 T Ohshio,1 S Tominaga2 and M Ohtsuki1 1 Dermatology, Jichi 
Medical University, Shimotsuke, Japan and 2 Biochemistry, Jichi Medical University, 
Shimotsuke, Japan
[Background] IL-33 is one of the members of IL-1 cytokine family, constitutively expressed in the 
nucleus of endothelial and epithelial cells. It is released from the cells following mechanical or 
chemical damage, and serves as “alarmin” similar to high mobility group box (HMGB)1. We have 
previously reported that IL-33 is induced by UV-B, IFNγ or IL-17A in Normal Human Epidermal 
Keratinocytes (NHEKs). Our previous report demonstrated that induction of IL-33 by IFNγ was 
dependent on STAT1 and ERK. [Objectives] The mRNA of human IL-33 (hIL-33) is composed of 8 
exons including non-coding exon1. It was confirmed that there were three different transcription 
products of IL-33, each containing one of three distinct exon1s; i.e., exon1a, 1b and 1c. We have 
previously reported that transcription of hIL-33 in NHEKs utilized exon1c, which located at the 
most proximity to exon2. However, the promoter region of hIL-33 and its transcriptional regulation 
were unknown. [Methods] We amplified approximately 2.5 kbp region of the 5’ UTR of each three 
exon1 with PCR and cloned them into upstream of firefly luciferase gene construct. These constructs 
were transfected to NHEKs, Human Umbilical Endothelial Cells (HUVECs) and Normal Human 
Dermal Fibroblasts (NHDFs), stimulated with IFNγ or TNFα, and luciferase assay was performed. 
[Results] The constructs containing 5’ UTR of exon1a or exon1b had no luciferase activity in neither 
of these cells, while the construct containing exon1c had high basal activity in NHEKs, HUVECs 
and NHDFs. This construct well responded to IFNγ in NHEKs and HUVECs, but did not respond 
to IFNγ in NHDFs. TNFα did not induce promoter activity from neither of these three constructs in 
neither of cell types investigated in this time. [Conclusion] The active promoter region of IL-33 was 
identified. The regulation of IL-33 transcription in NHEKs, HUVECs, and NHFDs was dependent 
on the same promoter, which may utilize common transcription factors.    
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Different Z-DNAs in human melanoma: Stages 0 to IV
CE Gagna,1,2,3 AE Skiadas,1 PC Lambert,4 D Dursunian,1 M Malik,1 A Sharma1 and 
W Lambert2,3 1 Life Sciences, New York Institute of Technology, Old Westbury, NY, 2 
Dermatology (Medicine), Rutgers New Jersey Medical School, Newark, NJ, 3 Pathology & 
Laboratory Medicine, Rutgers New Jersey Medical School, Newark, NJ and 4 St. Georges 
University School of Medicine, St. Georges, Grenada
Cutaneous malignant melanoma is a neoplasm that develops from melanocytes that can occur 
de novo or from a lesion. Two growth phases, radial and vertical, are recognized in melanoma. 
Epigenetics, and genomics must be used to discover new DNA, and DNA-protein target sites. This 
could result in new drugs that can be used to cure melanoma. Left-handed double-stranded (ds-) 
Z-DNA is an exotic form of the more frequently found ds-B-DNA. Z-DNA plays a role in regulating 
gene expression and transcription. We immunohistochemically stained melanoma tissue sections 
using a novel technique that preserves non-denatured nucleic acids. Additionally, we used novel 
intact, non-denatured DNA microarrays to support our immunochemical results. We employed 
several polyclonal and monoclonal anti-Z-DNA antibodies, and Z-DNA binding proteins that rec-
ognize specific base pair combinations, A comparative histopathological approach was taken using 
tissue fixed in either 70% ethanol, Davidson’s solution, Carnoy’s solution or 10% neutral buffered 
formalin to examine the presence and distribution of Z-DNA and Z-DNA-protein complexes. Using a 
sophisticated computer image analysis software system, we characterized the cutaneous melanoma’s 
two growth phases. We have observed the distribution of Z-DNA within melanoma as it proceeds 
from Stages 0 to IV. Based on our data, we believe that specific types of Z-DNA exist within mutated 
melanoma genes. These different types of Z-DNA manifest themselves during different stages of 
this disease (Stages 0 - IV). Increased levels of different Z-DNAs have been found within different 
regions of the malignant growths. The capability to target different Z-DNAs in epidermal genes will 
allow for new DNA and protein target sites in the genome and proteome. This will allow for the 
construction of new drugs to treat melanoma at different stages of development.    
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Bioinformatics of Z-RNA in human melanoma
CE Gagna,1,2,3 W Lambert2,3 and AE Skiadas1 1 Life Sciences, New York Institute of 
Technology, Old Westbury, NY, 2 Pathology & Laboratory Medicine, Rutgers New Jersey 
Medical School, Newark, NJ and 3 Dermatology (Medicine), Rutgers New Jersey Medical 
School, Newark, NJ
About 160,000 new cases of melanoma are diagnosed annually worldwide. Human melanoma 
accounts for about 4% of all cases of skin cancers, however it is responsible for about 80% of 
skin cancer deaths. Z-DNA and Z-RNA are alternative types of nucleic acid structures that help 
regulate normal and diseased genomes. Z-DNA is believed to be one of three biologically active 
double-stranded (ds-) DNA structures along with A-DNA and B-DNA. Ds-Z-DNA sequences are 
often located in genetic “hot spots”, areas of DNA known to be susceptible to genetic rearrange-
ments linked with cancer. Z-DNA is a high energy form of ds-DNA, unlike the more stable ds-B-
DNA. Our group has used bioinformatics, Z-RNA microarrays, and novel immunohistochemical 
and ELISA techniques to identify the presence, and characterize the structure, of different Z-RNA 
segments in human melanoma genomes. Bioinformatics software, such as the Z-Hunt computer 
software system, and RNA structure prediction software was used to find genetic elements that 
have potential Z-RNA sequences. Our results showed that some mutated epidermal genetic factors 
contain potential Z-RNA-forming sequences. A variety of different Z-RNA sequence segments have 
been characterized. New classes of RNA-based drugs that can be employed to treat and/or cure 
melanoma need to be made, namely, to bind to Z-RNA and “turn off” gene expression. These types 
of bioinformatics studies along with next generation RNA microarray experimentation will help 
develop new strategies for treating melanoma. Being able to locate Z-RNA in the process of studying 
melanoma cancers will facilitate the discovery of additional target sites with the goal of producing 
novel drugs based on A-RNA to Z-RNA transitions.    
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Polymorphisms of NFκB1 (-94 del/insATTG), NFκB1A (2758 A>G) and SUMO (rs237025 
G>A) genes in psoriasis
A Al-Zolibani,1 A Ali,3 A Settin2 and A Alrobaee1 1 Dermatology, Qassim University, 
Buraydah, Saudi Arabia, 2 Pediatrics, Qassim University, Buraydah, Saudi Arabia and 3 
Biochemistry, Qassim University, Buraydah, Saudi Arabia
Background: Nuclear factor-κB (NF-κB),is a key transcription factor involved in the regulation of 
immune responses and apoptosis. The small ubiquitin-like modifier, (SUMO4) is a negative regulator 
of NF-κB in the cell-signaling pathway. The study aimed to test for the association of the NF-κB1, 
NFκBIAand SUMO gene polymorphisms with the susceptibility and severity of psoriasis among 
Saudi cases. Subjects and Methods: Thisisa case controlled study including 85 Saudi psoriasis 
patients in addition to 92 matched healthy unrelated controls from the same locality. DNAwas 
analyzed by real time PCR for SUMO (rs237025 G>A)and restriction fragment length polymorphism 
(RFLP) for NF-κB 1 (-94 del/insATTG) and NF-κB IA (2758 A>G)gene polymorphisms. Results: 
Although statistically nonsignificant, cases had higher frequencies of certain genotypes compared 
to controls as SUMO4 GG (25% vs. 19.6%), NF-κ B1 ins/del (48.8% vs. 41.3%) and NF-κB1A GG 
(56.8% vs. 43.2%)genotypes. Cases with the plaque type had significantly higher frequency of the 
SUMO4 TT genotype than the guttate type (24.3% vs. 11.1%, p=0.015) with also a higher frequency 
of the NF-κB1A GG genotype (35.7% vs. 0.0%, p=0.038). The PASI score was also significantly 
higher among cases with the NF-κB1A AA genotype (p=0.001). Conclusion:Genetic polymorphisms 
of SUMO4 rs237025 G>A,NF-κB1-94 ins/del ATTG and NF-κB IA (2758 A>G)were not associated 
with the susceptibility of psoriasis vulgaris. However, they were associated with psoriasis clinical 
types and the age of onset of the disease. Keywords: Psoriasis; Gene polymorphism;Psoriasis; 
Nuclear factor kappa-B1 (NF-κB1), Small ubiquitin-related modifier4 (SUMO4).    
439
Sequencing-based approach identified three new psoriasis susceptibility loci for psoriasis
Y Sheng,1,2,3 J Gao,1,2,3 Y Li,1,2,3 L Sun,1,2,3 Y Cui,1,2,3 S Yang1,2,3 and X Zhang1,2,3 1 Department 
of Dermatology and Venereology, Anhui Medical University, Hefei, China, 2 Institute of 
Dermatology and Department of Dermatology at No.1 Hospital, Anhui Medical University, 
Hefei, China and 3 Key Laboratory of Dermatology, Anhui Medical University, Ministry of 
Education, China, Hefei, China
Psoriasis is a chronic and multifactorial skin disease characterized by sharply demarcated erythema-
tous plaques with adherent silvery scales. Our understanding of the genetic architecture of psoriasis 
has increased rapidly due to genome-wide association studies (GWASs), which have identified more 
than 40 psoriasis susceptibility genes/loci. In a previous large-scale exome sequencing analysis for 
psoriasis, we discovered 7 common and low frequency missense variants within 6 genes at genome-
wide significance. To explore additional psoriasis susceptibility loci, we performed an in-depth 
analysis focusing on non-coding variants based on the sequencing data (10,727 cases and 10,582 
controls) and replication in an independent cohort of Han Chinese individuals consisting of 4,480 
cases and 6,521 controls. We confirmed 4 known psoriasis susceptibility loci and identified 3 new 
susceptibility loci. Two suggestive loci were also identified with P < 1.00×10-06. Gene expression 
analysis based on public databases of psoriasis indicated that all of these new susceptibility genes 
showed highly differential expression between psoriasis lesions and healthy skins from both psoriasis 
cases and controls. The results of this study increase the number of confirmed psoriasis risk loci and 
throw novel insights into our understanding on the pathogenesis of psoriasis.    
Genetic Diseases/Gene Regulation/ Gene Therapy | ABSTRACTS
www.jidonline.org   S77
440
A B-lymphoproliferative disorder is associated with severe skin erosions in AEC syndrome
M Mollo,1 L Cirillo,1 A Sirico,1 D Antonini1 and C Missero1,2 1 CEINGE, Center for Genetic 
Engineering, Napoli, Italy and 2 University of Naples Federico II, Napoli, Italy
AEC (Ankyloblepharon- Ectodermal defects Cleft lip/palate) syndrome is an autosomal dominant 
disorder, caused by missense mutations in p63 and characterized by skin erosions, ectodermal 
dysplasia and cleft lip and/or palate. To elucidate the molecular mechanisms associated with the 
pathogenesis of AEC syndrome, we generated a conditional knock-in mouse model carrying the 
clinically relevant L514F human mutation. p63L514F/L514F mice were crossed with a K14-Cre 
transgenic line that allows expression just before birth. Mutant mice developed a progressively 
strong phenotype, characterized by skin erosions, skin crusting and hair loss, causing early death in 
a high percentage of mutant mice. In vivo only a subset of known p63 target genes were affected in 
mutant epidermis, whereas a much broader number of epidermal-specific genes were deregulated 
in cultured mutant keratinocytes. Reduced epidermal integrity and altered differentiation led to a 
progressive inflammation characterized by hyperplasia and hyperkeratosis, and massive infiltration 
of macrophages and mast cells in the dermis. Clear signs of severe inflammation were accompanied 
by production of Thymic Stromal Lymphopoietin (TSLP), an IL-7 like cytokine. Epidermal-derived 
TSLP was detected at high levels in peripheral blood, and was associated with a B-lymphoprolifer-
ative disorder characterized by an increase in immature B cells. Interestingly a similar autoimmune 
disorder has been observed in at least one AEC patient with severe skin erosions. Our data indicate 
that p63 is a critical regulator of epidermal integrity and differentiation, and that severe epidermal 
alterations in AEC syndrome can drive an autoimmune systemic disorder.    
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A novel nonsense PTCH1 mutation in a Chinese family with nevoid basal cell carcinoma 
syndrome
W Jiang,1 D Gao2 and E Huang3 1 Dermatology, Peking University Third Hospital, Beijing, 
China, 2 Dermatology, Peking University Third Hospital, Beijing, China and 3 Dermatology, 
Peking University Third Hospital, Beijing, China
BACKGROUND: Nevoid basal cell carcinoma (NBCCS; MIM 109400) is an autosomal-dominant 
disorder, characterized by tumorigenesis and developmental defects and caused by mutations on 
chromosome 9q22 in the PTCH1 gene (601309), the PTCH2 gene (603673) on 1p32, or the SUFU 
gene (607035) on 10q24-q25. In most cases, the hedgehog receptor patched1 (PTCH1) has been 
identified as the gene mutated in NBCCS. So it is important to define the specific mutation with 
a Chinese family with NBCCS. OBJECTIVE: The aim of this study was to detect the PTCH1 gene 
mutation in a Chinese family with NBCCS. METHOD: Genomic DNA of the family members and 
a cohort of healthy individuals were isolated and subjected to polymerase chain reaction (PCR) 
and direct DNA sequencing. RESULTS: One nonsense PTCH1 gene mutation was identified in the 
proband and his son The mutation, (C.2137C>T in exon14) is predicted to lead to different PTCH 
protein translation (Q713X). These mutations were not found in unrelated healthy Chinese people. 
CONCLUTION: We have identified one nonsense mutation within the PTCH1 gene associated 
with a Chinese family with NBCCS.    
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A genome-wide association study of pemphigus vulgaris
J Gao,1,2,3 Y Sheng,1,2,3 Y Li,1,2,3 Y Cui,1,2,3 L Sun,1,2,3 S Yang1,2,3 and X Zhang1,2,4 1 Department 
of Dermatology and Venerology at No.1 Hospital, Anhui Medical University, Hefei, China, 
2 Institute of Dermatology, Anhui Medical University, Hefei, China, 3 Key Laboratory of 
Dermatology, Anhui Medical University, Hefei, China and 4 Institute of Dermatology, 
Huashan Hospital of Fudan University, Shanghai, China
To identify additional genetic susceptibility loci for PV, we performed a genome-wide association 
study (GWAS) using 4135 samples. In the discovery stage, we analyzed autosomal SNPs in 96 cases 
and 1,095 controls, 2 SNPs (P= 9.90 × 10 −11, OR = 5.24) within the major histocompatibility 
complex locus was found with significant association, which is consist with previously reported. 
We selected the 76 promising SNPs to validate in the replication stage with a total of 509 cases and 
2,435 controls. The combined analysis identified a missense variant (Pcombined = 4.0 × 10-11, 
OR = 11.19) of NCR3, which encoded protein interacts with T-cell receptor, associated with PV. In 
addition, we also confirmed rs1073208 at 3p22.3 (P = 4.25× 10-2, OR = 0.70), previously reported 
susceptibility locus, associated with PV. In conclusion, our study demonstrated that genetic suscep-
tibility of PV is related with MHC region, which is consistent with previously reported in European 
population, and portend a better understanding the mechanism of PV.    
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Significant association of X gene variants on development of dermatomyositis in the Han 
Chinese population
Y Li, C Zhang, Y Sheng, J Gao, L Sun, Y Cui, S Yang and X Zhang Department of Dermatology, 
The First Affiliated Hospital, Anhui Medical University, Institute of Dermatology, Anhui 
Medical University, Hefei, China
Dermatomyositis (DM) is a rare and complex autoimmune diseases which is affected by immuno-
genetic and environmental factors. To identify DM susceptibility genes, we performed a genome-
wide association study (GWAS) of DM in 127 patients and 1,566 controls from Han Chinese 
using Illumina HumanOmniZhongHua-8 BeadChips. We also investigated whether 189 single 
nucleotide polymorphisms (SNPs) which previously associated with other autoimmune diseases 
are also predispose to DM in our GWAS data. Moreover, we selected 44 SNPs (P < 10 × 10−7 or 
previously reported predisposed to DM) to perform the Haplotype analysis. In this study, there were 
8 SNPs significantly associated with DM in the X gene region (P < 5 × 10−8). The other two SNPs 
in two genes (Y gene and Z gene) were also associated with DM (P= 6.70 × 10−4,P= 1.63 × 10−3, 
respectively). Haplotype analysis indicated that two Haplotypes (M and N) were associated with 
DM (P= 4.52 × 10−10, P= 3.02 × 10−10, respectively) other than that in Caucasian. In conclusion, 
we identified the X gene significant associated with DM in Han Chinese subjects. Moreover, spe-
cific SNPs are very different from previously reported candidate gene studies that associated this 
region with DM in other populations worldwide, and there are the presence of novel haplotypes 
associated with DM in Han Chinese ancestry. Our study shows that DM may share genetic features 
with other autoimmune diseases and infectious disorders, which maybe contributes to improve our 
understanding of DM etiopathogenesis, novel diagnoses and therapies.    
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Higher-order chromatin folding and coordinated gene regulation at the Epidermal Differen-
tiation Complex (EDC) locus in keratinocytes
J Yarker,1 K Poterlowicz,1 N Naumova,2 B Lajoie,2 A Mardaryev,1 A Sharov,3 J Dekker,2 
VA Botchkarev1,3 and M Fessing1 1 University of Bradford, Bradford, United Kingdom, 2 
University of Massachusetts Medical School, Worcester, MA and 3 Boston University School 
of Medicine, Boston, MA
The EDC locus contains multiple co-regulated genes involved in epidermal keratinocyte (KC) differ-
entiation. Molecular mechanisms controlling the co-ordinated gene transcription at the EDC remain 
elusive. We used chromatin conformation capture (5C) technology to compare the high-resolution 
spatial genomic proximity network within 5Mb domain containing EDC and its flanking regions 
between mouse epidermal KCs and thymocytes (TCs). Transcription profiling shows markedly 
increased gene expression levels in central EDC domain in KCs in comparison to TCs, while flank-
ing regions have more similar expression levels in both cell types. Chromatin at the EDC and its 
flanking regions form several topologically associated domains (TADs) with similar borders, which, 
however, showed markedly different intra-domain folding in KCs versus TCs: two adjacent TADs 
at the EDC central part were more condensed and non-randomly folded in KCs versus TCs. ChIP-
seq analysis of the enhancer-specific histone modifications revealed that substantial number of the 
spatial chromatin interaction at the EDC in KCs involves promoter-enhancer, enhancer-enhancer 
and promoter-promoter contacts, suggesting the existence of specific three-dimensional interaction 
network between proximal and distal gene regulatory elements controlling co-ordinated gene tran-
scription at the EDC. Correlation of 5C data with ChIP-seq data for several regulators of chromatin 
architecture (Satb1, Brg1, Ctcf, cohesin) suggests that these proteins act to control KC-specific 
folding of chromatin at the EDC. In summary, our data map the spatial interaction network between 
gene regulatory regions controlling co-ordinated gene expression at the EDC locus and provide 
an important platform for further study of higher order chromatin folding at KC-specific genomic 
loci involved in controlling gene expression programmes in skin epithelia in health and disease.   
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An organotypic psoriasis tissue model for evaluation of drug therapeutics
S Ayehunie, C Hedin, A Cataldo, M Spratt, MA Bachelor, PJ Hayden and M Klausner MatTek 
Corporation, Ashland, MA
Psoriasis is an inflammatory skin disease marked by hyperfliferation and abnormal keratinocyte 
differentiation that affects 1-3% of the global population. Availability of a differentiated psoriatic 
tissue model that accurately reflects the biology of the psoriatic phenotypes will increase basic 
understanding and facilitate drug discovery. In the current study, normal human keratinocytes 
and psoriatic fibroblasts from lesional and non-lesional sites were harvested from primary tissue 
and cultured using serum-free medium to form a highly differentiated 3-dimensional tissue model. 
The tissue model was characterized for histological features, gene expression and cytokine release 
indicative of the psoriatic phenotype. Results showed that psoriatic fibroblasts from both lesional 
and non-lesional sites can induce psoriatic phenotype in vitro. Gene expression analysis showed 
overexpression of several biomarkers commonly elevated in psoriatic lesions including HBD-2, 
psoriasin, elafin, and CXCL5 (ENA-78), similar to the in vivo situation. Cytokine analysis of cul-
ture supernatants from the psoriatic tissue model (containing normal keratinocytes and lesional 
fibroblasts) showed increased release of IL-6 (7 fold), IL-8 (5.5 fold), and GRO-α (3.8 fold) when 
compared to tissues reconstructed from non-psoriatic skin samples. Confocal microscopic evalua-
tion of the psoriatic tissue model revealed: 1) hyperproliferation of basal epithelial cells (increase 
Ki67 staining), 2) increased psoriasin, elafin, and CK16, expression, 3) reduced levels of filaggrin, 
and 4) a standard pattern of cytokeratin 10 expressions, similar to that of psoriatic skin. Topical 
treatment of the psoriatic tissue model with three over-the-counter psoriatic drugs (calcipotriol 
hydrate, MG217, and psoriasin gel) decreased HBD-2, psoriasin, elafin, and CXCL5 (ENA-78) gene 
expression. In conclusion, the availability of well characterized in vitro psoriatic tissue model is 
anticipated to be a valuable tool to study the biology of psoriasis and to accelerate the development 
of therapeutic candidates.    
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Exome array analysis identifies 14 new susceptibility loci for psoriasis
Y Sheng, Y Li, L Sun, Y Cui, S Yang and X Zhang Department of Dermatology at No.1 
Hospital, Anhui Medical University, Hefei, China
Psoriasis is a chronic inflammatory hyperproliferative skin disease with dynamic interactions 
between the immune system and the skin and affects up to 3% of the population worldwide. Both 
genetic and environmental factors contribute to psoriasis. More than 40 susceptibility loci associated 
with psoriasis were identified through genome-wide association studies (GWAS). However, these 
‘‘identified’’ genes/loci only explained a small proportion of the genetic contribution, and most of 
the identified risk variants showing the most significant disease association map to genomic regions 
with no obvious function, thus providing few clues as to how causal variants affect the disease gene.
To detect coding variants for psoriasis, we carried out three-stage case-control association study 
in three independentcohorts consisting of a Han Chinese population, including 17,622cases and 
25,147 controls, using custom Illumina HumanExome Asian Beadchip, Illumina HumanExome 
Beadchip and Sequenom Massarray system. In the MHC region, many SNPs showed genome-wide 
significant association (P < 5 × 10−8). Further conditional association analysis of the these SNPs 
confirmed that there were five independent signals in MHC region(Including A,B,C,D,E ). For non-
MHC region, we identified 16 SNPs within 14 new loci associated with psoriasis (P combined< 5 
× 10−8), including 11 coding variants and 5 non-coding variants. In addition, we also replicated 8 
known susceptibility loci IL23R, TNIP1, IFIH1, NFKBIA, IL12B, MTHFR, ZNF816A and LCE gene 
cluster (P combined< 5 × 10−8). Our findings increase the number of genetic risk factors for psoriasis 
and highlight new and plausible biological pathways in psoriasis.    
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Downregulation of DNA repair by an antimycotic drug leads to a phenotype resembling 
Xeroderma pigmentosum and to increased skin cancer
S Giovannini,2 Y Kamenisch,2 N Kobert,3 L Weibel,3 L French,3 M Röcken1 and M Berneburg2 
1 Dermatology, Eberhard Karls University, Tübingen, Germany, 2 Dermatology, 
Universitätsklinikum Regensburg, Regensburg, Germany and 3 Children, University Children, 
Zürich, Switzerland
Prophylactic protection of patients with severe immunosuppression is of vital importance to shield 
the patient from opportunistic fungal infections. It has been reported, that patients treated with a 
broad spectrum antimycotic drug(AD) develop adverse effects such as phototoxicity followed by 
pigmentary changes and the development of ultraviolet radiation (UV) associated non melanoma 
skin tumours. Thus, patients closely resemble the phenotype of the progeroid disorder xeroderma 
pigmentosum (XP), known to be caused by a defect in the DNA repair mechanism nucleotide exci-
sion repair (NER). So far the underlying molecular mechanisms by which AD leads to the XP-like 
clinical phenotype have not been clarified. Therefore, we investigated if AD leads to a reduction of 
DNA repair and increased DNA damage. We found that long term treatment lead to suppression 
of unscheduled DNA synthesis as well as increased comet formation while double strand breaks 
were not induced. Importantly repair suppressive effects were transient since removal lead to nor-
malization of all repair associated parameters. Furthermore, compound treatment did not cause 
significant transcriptional regulation of mRNA levels of NER proteins such as XPA – G, ERCC1, 
XAP and RAD23 A/B. Interestingly we found a higher level of Mdm2, XPB and XPD proteins in 
complex with p53. This result suggests an interference of AD with these complexes. When exposed 
to the compound cells also did not show cell cycle arrest even in the presence of DNA damage but 
proliferated similar to untreated controls. Initial in silico molecular alignment indicates possible 
interference with sterical binding of the p53/MDM2 complex. Taken together these results indicate 
that the broad spectrum antimycotic could suppress NER, increase DNA damage and thus, lead to 
photosensitivity, pigmentary changes and ultimately non melanoma skin tumors.    
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Widespread genomic blocks of hypomethylation in nonmalignant epidermis related to age 
and sun exposure
A Vandiver,1 R Irizzary,2 K Hansen,3 L Garza,4 A Runarsson,1 X Li,1 AL Chien,4 SG Leung,4 
S Kang4 and AP Feinberg1,5 1 Center for Epigenetics, Johns Hopkins School of Medicine, 
Baltimore, MD, 2 Dana-Farber Cancer Institute, Boston, MA, 3 Biostatistics and Institute 
for Genetic Medicine, Johns Hopkins School of Medicine, Baltimore, MD, 4 Dermatology, 
Johns Hopkins School of Medicine, Baltimore, MD and 5 Medicine, Johns Hopkins School 
of Medicine, Baltimore, MD
Epigenetic changes such as DNA methylation are established mechanisms for cancer, with an 
emerging role in aging. Identical twin studies have shown markedly divergent patterns of DNA 
methylation in whole blood over the lifespan, suggesting an environmental component to epigenetic 
change with age. The skin offers an opportunity to study the influence of environmental factors on 
the epigenome by virtue of its direct exposure to the sun. Here we asked whether DNA methylation 
is altered with aging and/or chronic sun exposure in skin. We compared epidermis and dermis of 
both sun-protected and sun-exposed skin obtained from younger subjects (under 35 years) and older 
subjects (over 60 years), using the Infinium HumanMethylation450 array. Surprisingly, we observed 
large blocks of the genome, encompassing 670 Mb, hypomethylated only in epidermal samples 
affected by both aging and sun exposure. We confirmed these findings using whole genome bisulfite 
sequencing to compare epidermis from 3 younger and 3 older subjects. The degree of hypomethyl-
ation in sun-exposed skin is correlated with Griffiths photonumeric scale for photoaged skin (R2 = 
0.61, P= 0.0002). The locations of hypomethylated blocks observed with aging and sun-exposure 
overlap strongly with regions previously identified as hypomethylated blocks in cancer (Odds Ratio 
8.5), heterochromatin domains (Odds Ratio 3.4) and lamin-associated domains (Odds Ratio 3.5). 
These data suggest that photo-aging may be linked to large scale epigenomic change, offering targets 
for further study and potential intervention.    
449
Intravenously administered type VII collagen derived from genetically engineered Chinese 
ovarian hamster cells reverses the DEB disease phenotype in C7-knockout mice: Implications 
for available DEB therapy
Y Hou,1 T Wu,1 R Gao,1 E Hong,1 J Cogan,1 D Keene,2 N Liu,3 Y Huang,3 O Francone,3 
L Guey,3 DT Woodley1 and M Chen1 1 Dermatology, University of Southern California, Los 
Angeles, CA, 2 Shriners Hospital for Children, Portland, OR and 3 Shire, Lexington, MA
Dystrophic epidermolysis bullosa (DEB) is an inherited disorder characterized by skin fragility, blis-
tering and multiple skin wounds due to mutations in the gene encoding type VII collagen (C7). Using 
recombinant C7 (rC7) purified from molecularly-engineered recessive DEB (RDEB) fibroblasts, we 
showed previously that intravenously (IV) injected rC7 homed to engrafted RDEB skin, incorporated 
into its dermal-epidermal junction (DEJ) and reversed the RDEB disease phenotype. Nevertheless, 
human dermal fibroblasts are not commonly used for commercial production of therapeutic proteins. 
Chinese hamster ovary (CHO) cell lines, in contrast, are widely used for large-scale production 
of recombinant therapeutic proteins. In this study, we characterized the structural and functional 
properties of CHO-derived recombinant C7 (CHO-rC7) generated by a Contract Manufacturing 
Organization and compared it with fibroblast-derived C7 (FB-rC7). We found that CHO-rC7 is 
similar to FB-rC7 by a number of criteria including its ability to assemble into trimers, to form a 
stable triple helical domain resistant to protease digestion, to promote keratinocyte migration, and 
to bind to fibronectin. We next IV injected a single dose (16 μg) of purified CHO-rC7 or FB-rC7 into 
new-born C7 null DEB mice (Col7a1-/-) and found that both FB-rC7 and CHO-rC7 transported and 
incorporated into the DEJ of multiple skin sites, the tongue and the esophagus. The restoration of 
C7 corrected disease features, including dermal-epidermal separation and anchoring fibril defects 
and increased the life span of the animals. We conclude that this CHO-rC7 material is as effective 
as FB-rC7 in correcting DEB in a preclinical animal model. These studies advance the prospects 
for IV based protein therapy for DEB patients.    
450
ABCA5 is a novel regulator of hair growth
GM DeStefano,1 M Kurban,1 K Anyane-Yeboa,1 C Dall’Armi,1 G Di Paolo,1 H Feenstra,2 
N Silverberg,2 L Rohena,1 V Jobanputra,1 K Fantauzzo,1 M Kiuru,1 M Tadin-Strapps,1 
A Sobrino,3 A Vitebsky,1 D Warburton,1 B Levy,1 JC Salas-Alanis,4 LD Lopez-Cepeda5 and 
A Christiano1 1 Columbia University, NY, NY, 2 St. Luke’s-Roosevelt, NY, NY, 3 New York 
Presbyterian Hospital, NY, NY, 4 Universidad de Monterrey, Monterrey, Mexico and 5 
Centro Dermatologico Pascua, Mexico, Mexico
Inherited hypertrichoses are rare syndromes characterized by excessive hair growth that does not 
result from androgen stimulation, and are often associated with additional congenital abnormali-
ties. In this study, we investigated the genetic basis of autosomal recessive congenital generalized 
hypertrichosis terminalis (CGHT) (OMIM135400) in a consanguineous family using whole-exome 
sequencing. We identified a single base pair substitution in the 5’ donor splice site of intron 32 in 
the ABC lipid transporter gene ABCA5 that leads to aberrant splicing of the transcript. We found high 
levels of ABCA5 expression in both epithelial and mesenchymal compartments of control human 
skin and hair follicles, which was significantly reduced or completely lost in CGHT hair follicles. 
The disruption of ABCA5 leads to reduced lysosome function, which results in the accumulation of 
autophagosomes, autophagosomal cargos as well as increased endolysosomal cholesterol in CGHT 
keratinocytes. In an unrelated sporadic case of CGHT, we identified a 1.3 Mb cryptic deletion of 
chr17q24.2-q24.3 encompassing ABCA5 and found that ABCA5 levels are dramatically reduced 
throughout patient hair follicles. Our findings suggest a novel, previously unrecognized role for 
ABCA5 in regulating hair growth.    
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Genetic basis of congenital wound disorders: Aplasia cutis congenita
A Marneros Dermatology, Massachusetts General Hospital/Harvard Medical School, Boston, 
MA
Genodermatoses that manifest with a wound at birth provide the opportunity to identify novel genes 
that are important for skin morphogenesis. Aplasia cutis congenita (ACC) is such a genodermatosis 
that presents with a scalp skin defect at birth, usually healing with a thick hypertrophic scar. We 
have identified several families with autosomal dominant ACC. We have combined genome-wide 
linkage analysis with exome sequencing approaches to identify the genetic basis of ACC. A mutation 
in the ribosomal biogenesis GTPase BMS1 was identified in autosomal dominant ACC. This muta-
tion results in a loss-of-function BMS1 allele and leads to a defect in pre-rRNA maturation of the 
small ribosomal subunit and subsequently a nucleolar stress response. The ribosomal dysfunction 
causes p21 activation and a G1/S phase arrest that leads to a reduced cell proliferation rate. Global 
proteomic and transcriptomic analyses confirmed a central role of p21 for the ACC phenotype. We 
speculate that elevated p21 levels due to a ribosome biogenesis defect impairs both cell proliferation 
and differentiation of keratinocytes during embryonic development. This work identifies ACC as a 
novel ribosomopathy and provides a previously not appreciated link between ribosome biogenesis 
and skin morphogenesis. Additional work demonstrated genetic heterogeneity in ACC, raising the 
possibility to identify further ACC genes.    
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Identification of alopecia areata relevant copy number variants
L Bian,1 L Petukhova,1,2 J Cerise1 and A Christiano1,3 1 Dermatology, Columbia, NY, NY, 
2 Epidemiology, Columbia, NY, NY and 3 Genetics and Development, Columbia, NY, NY
Alopecia Areata (AA) is a common human autoimmune diseases characterized by hair loss due to 
immune attack on the hair follicle. Although GWAS have succeeded in identifying AA-associated 
SNPs, the contribution of copy number variants (CNVs) to AA has not yet been determined. Using 
our previous GWAS genotyping data,we extracted CNV data for 1,080 AA patients using the Pen-
nCNV. The CNVs were compared to the Database of Genomic Variants (DGV) to identify potential 
novel CNVs (defined as CNVs having <50% overlap with DGV) that are present only in AA patients. 
The novel CNVs were also compared to AA-associated regions from our GWAS. For genes directly 
disrupted by novel CNVs, enrichment analyses were performed to look for biological pathways 
that are over-represented in the AA-specific CNVs. A total of 27,840 CNVs (>1kb, 14,111 deletions 
and 13,729 duplications) were identified. 6,438 CNVs were defined as large CNVs with a length of 
>100kb (1,960 deletions and 4,478 duplications), among which 588 had only a single occurrence. 
A total of 340 CNVs have <50% overlap with DGV reports, and 87 are completely non-overlap-
ping with DGV. Ten novel CNVs fell within 500kb of AA-associated SNPs (p<10-4). Among the 
non-overlapping CNVs, only 1 is large, and 53 directly disrupt 62 genes. Among the remaining 253 
CNVs with <50% overlap with DGV reports, 104 are large and 81 of them directly affect 304 genes. 
Enrichment analysis (GO) showed the following biological processes are significantly enriched in 
the AA-specific CNVs: IL-1R binding, microtubule/cytoskeleton, translation factor activity, among 
others. KEGG analysis showed the top 10 enriched pathways included type 1 diabetes and rheuma-
toid arthritis, two autoimmune diseases that share similar genetic susceptibility with AA. We have 
performed validation assays on 45 novel CNVs involved in the enriched pathways, and 37 (82%) 
have been confirmed. Our findings identify a group of rare CNVs that may be unique to AA, and 
disrupting important genes in autoimmune disease pathogenesis.    
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Corrected patient-specific, iPSC-derived epithelial sheets for dystrophic epidermolysis bullosa
V Sebastiano,2 H Zhen,1 P Wang,1 B Haddad,2 E Bashkirova,1 M Ameen,1 Z Siprashvili,1 
S Melo,1 J Li,1 S Kim,1 A Lane,1 M Wernig2 and A Oro1 1 Program in Epithelial Biology, 
Stanford, Stanford, CA and 2 Pathology, Stanford, Stanford, CA
Patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) lack functional Collagen VII 
due to mutations in the COL7A1 locus and suffer from severe blistering. While chronic wounding 
leaves many patients lacking sufficient epidermal stem cells, the discovery of induced pleuripotent 
stem cell (IPSC) technology brings hope to produce corrected, patient-specific iPSCs as a source for 
generating unlimited wild-type epithelial tissues. Here we describe a 48-week procedure to generate 
corrected patient-specific epithelial sheets. IPSCs were generated from the cells of 3 patients using 
a floxed lentivirus carrying the 4 reprogramming factors, allowing for reversible excision of the 
factors prior to differentiation. COL7A1-corrected iPSCs from two patients resulted from using both 
traditional homologous recombination (HR), and a recently identified Adeno-associated viral variant, 
AAVDJ,with the latter generating corrected clones with a 40-65% frequency. Corrected, looped 
out iPSCs with both the reprogramming and HR cassettes removed were characterized for their 
pluripotency and normal diploid karyotype. Given the tumor-susceptibility of this patient population, 
we performed whole genome sequencing on patient cells and iPSCs and found the accumulation 
of tumor-predisposing Notch mutations in 2 out of 3 clones, allowing us to remove non-mutant 
clones prior to differentiation. Corrected iPSCs were in-vitro differentiated into functional, K14+/
K18- keratinocytes using an embryoid body-based method and the resulting cells closely resem-
bled the patients original keratinocytes by microarray analysis. IPSC-derived keratinocytes formed 
stratified epithelial layers and mature skin markers in organotypic cultures, as well as in 3-week 
transplanted NOG mice, although a mature basement membrane zone and anchoring fibrils were 
not yet observed. In summary, we provide pre-clinical support demonstrating a relatively efficient 
protocol for the use of iPSC in the clinical treatment of RDEB.    
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Sirolimus normalizes skin and dramatically reduces internal tumors in a mouse model of 
tuberous sclerosis complex (TSC)
P Klover,1 R Thangapazham,1 J Kato,2 J Wang,1 S Li,1 SA Anderson,3 V Hoffmann,3 E McCart,1 
N Nathan,1,2 J Moss2 and TN Darling1 1 Uniformed Services University, Bethesda, MD, 2 
Cardiovascular and Pulmonary Branch, National Heart, Lung, and Blood Institute, NIH, 
Bethesda, MD and 3 Diagnostic and Research Services Branch, NIH, Bethesda, MD
TSC skin tumors display a thickened dermis containing fibroblasts that show overactivation of 
mTORC1 signaling due to inactivation of TSC1 or TSC2. To develop a model of TSC skin tumors, 
mice with floxed Tsc2 alleles were mated with Prrx1-cre mice in which cre is expressed in ventral 
skin and limb bud mesenchyme. Dermal fibroblasts from limb and ventral skin of Prrx1-cre mice 
with homozygous Tsc2 floxed alleles (Tsc2cKO) eliminated Tsc2 and had elevated phosphoS6, a 
marker of mTORC1 activation. The ventral and limb dermis of Tsc2cKO mice was nearly two-fold 
thicker than controls. Benign tumors developed in the skin, liver, spleen, and kidney, with nearly 
all Tsc2cKO mice developing forepaw vascular tumors and renal tubular adenomas by 4 and 12 
weeks of age, respectively. Median survival was 28 weeks of age. To test the role of mTORC1 in the 
development of tumors, sirolimus or vehicle was administered intraperitoneally every other day for 
30 days starting in mice about 25 days old. Sirolimus decreased the thickness of forepaws by 18% at 
day 24 (p=0.03) and 27% after 30 days (p<0.001) compared to vehicle. After 30 days of sirolimus, 
histopathological analysis revealed a 35% reduction (p=0.004) in dermal thickness compared to 
vehicle. Forepaw vascular tumors were present in 8/8 vehicle-treated mice, but undetectable in 
9/10 mice treated with sirolimus. Similarly, kidney and spleen tumors were present in 7/8 and 4/8 of 
vehicle-treated mice, respectively, but absent in mice treated with sirolimus. In summary, sirolimus 
decreases skin thickness and inhibits tumor formation in Tsc2cKO mice. The ability to noninvasively 
monitor tumor response to treatment and the earlier appearance of tumors with nearly complete 
penetrance suggest that this model is advantageous for testing response to therapies compared to 
heterozygous models of Tsc2 disruption.    
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Meta-analysis of genome-wide association studies in alopecia areata reveals new suscep-
tibility loci
L Petukhova,1 RC Betz,2 S Ripke,3,4 H Huang,4,5 A Menelaou,16 S Redler,2 T Becker,2 
S Heilmann,2 M Duvic,6 M Hordinsky,7 D Norris,8 V Price,9 J Mackay-Wiggan,1 GM DeStefano,1 
M Bohm,10 U Blume-Peytavi,11 H Wolff,12 G Lutz,13 R Kruse,14 B Blaumeiser,15 D Altshuler,3,4 
M Nothen,1 PI W de Bakker,16 M Daly3,4 and AM Christiano1 1 Columbia U, NY, NY, 2 U of 
Bonn, Bonn, Germany, 3 Mass General Hospital, Boston, MA, 4 Harvard U, Boston, MA, 5 
Broad Institute, Boston, MA, 6 MD Anderson, Houston, TX, 7 U of Minnesota, Minneapolis, 
MN, 8 U of Colorado, Denver, CO, 9 UCSF, San Franciscon, CA, 10 U of Münster, Münster, 
Germany, 11 Charité-Universitätsmedizin, Berlin, Germany, 12 U of Düsseldorf, Düsseldorf, 
Germany, 13 Hair and Nail, Wesseling, Germany, 14 Dermatological Practice, Paderborn, 
Germany, 15 U of Antwerp, Antwerp, Belgium and 16 U Med Center Utrecht, Utrecht, 
Netherlands
Alopecia areata (AA) is one of the most prevalent autoimmune diseases, in which the hair follicle 
is aberrantly attacked. Here, we performed the first meta-analysis in AA by combining GWAS and 
Immunochip data with replication data in a total of 2,807 cases and 6,975 controls. This analysis 
confirmed all previously identified loci and identified two new regions that exceed the threshold for 
statistical significance (p≤5x10-8): ACOXL/BCL2L11(Bim) at 2q13 (p=1.5x10-08); LRRC32 (GARP) 
at 11q13.5 (p=1.2x10-08). A third region achieved nominal significance: SH2B3(LNK)/ATXN2 at 
12q24.12 (p=1.3x10-07). Transcript and protein analysis of genes in these three regions demonstrate 
expression in disease relevant tissues. Imputation with SNPs in the HLA allowed us to test classical 
alleles and amino acid polymorphisms and indicate that the main MHC signal comes from amino 
acid position 37 in the HLA-DRB1 protein subunit (p=1x10-73). These data greatly expands our 
understanding of the genetic architecture of this highly prevalent autoimmune disease and further 
elucidates aberrant immune processes in disease etiology.    
456
Network-based modeling of skin and hair autoimmune susceptibility in alopecia areata
JC Chen,1,2 J Cerise,3 A Jabbari3 and A Christiano1,3 1 Genetics and Development, Columbia 
University, New York, NY, 2 Systems Biology, Columbia University, New York, NY and 3 
Dermatology, Columbia University, New York, NY
Alopecia areata (AA) is an autoimmune disease affecting the hair follicle in which T-cell infiltrates 
aberrantly localize to anagen hair follicles, resulting in different degrees of hair loss. While most 
research has focused on the immunologic etiology of the disease, little has been done to investigate 
the contributing genetics of the affected hair follicle in AA. Patients with autoimmune disease do 
not uniformly present with symptoms across multiple tissues, indicating that genetic components 
in the end organ specific to a disease are required for autoimmune response. Using our previ-
ously defined gene expression signatures associated with AA, here we utilized a systems biology 
approach to identify master regulators of autoimmune susceptibility. We postulate that an altered 
molecular state of scalp skin contributes to AA susceptibility, and using reverse-engineered cellular 
networks, we aimed to determine the key transcriptional regulators in scalp skin associated with the 
autoimmune response. From our expression data, we identified a set of transcriptional regulators 
that mediate both the onset and severity of AA. We found that the molecular states of AA can be 
regulated through a combination of ESRRG, IKZF1, HCLS1, DACH1, DLX4, and SOX15, wherein 
increasingly severe disease presentation required a higher fraction of regulators. Unexpectedly, 
we found that these changes are detectable in non-lesional scalp biopsies of patchy AA patients, 
suggesting that susceptibility may not be an acute, localized event, but may represent a molecular 
state that is present throughout scalp that is predisposed to an immune response. We propose that 
manipulation of these regulators could restore the immune-privileged environment of the hair 
follicle. The development of a regulatory framework for AA provides valuable insight into how the 
molecular state of the hair follicle contributes to the etiology of AA, and can serve as a model for 
deconstruction of complex diseases as regulatory processes.    
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Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the 
skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues
V Alexeev, J Uitto and O Igoucheva Dermatology and Cutaneous Biology, Thomas Jefferson 
University, Philadelphia, PA
The adult stem cells produce a plethora of extracellular matrix (ECM) molecules and have a high 
potential as cell-based therapeutics for connective tissue disorders of the skin. However, the primary 
challenge of the stem cell-based approach is associated with the inefficient homing of systemically 
infused stem cells to the skin. We examined chemotactic mechanisms that govern directional 
migration of the mesenchymal stem cells (MSCs) into the skin by conducting a comprehensive 
expression analysis of chemotactic molecules in MSCs and defined cutaneous tissues from nor-
mal and hereditary epidermolysis bullosa (EB)-affected skin. Analysis of chemokine receptors in 
short and long-term MSC cultures showed tissue culture-dependent expression of several receptors. 
Assessment of epidermis- and dermis-derived chemokines showed that majority of skin-originated 
chemotactic signals preferentially recruit different sets of leukocytes rather than MSCs. Analysis of 
the chemotactic molecules derived from EB-affected non-blistered skin showed only minor changes 
in expression of selected chemokines and receptors. Nevertheless, the data allowed us to define 
Ccl27-Ccr10 chemotactic axis as the most potent for the recruitment of MSCs to the skin. Our in 
vivo analysis demonstrated that uniform expression of Ccr10 on MSCs and alteration of Ccl27 
level in the skin enhance extravasation of stem cells from circulation and facilitate their migration 
within cutaneous tissue. Collectively, our study provides a comprehensive analysis of chemotactic 
signal in normal and EB-affected skin and proof-of-concept data demonstrating that alteration of the 
chemotactic pathways can enhance skin homing of the therapeutic stem cells.    
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A spontaneous mutation in the c-terminus of desmoplakin results in mice with a sparse, 
wavy coat
CH Pratt, H Fairfield, C Potter, I Greenstein, B Harris and JP Sundberg The Jackson 
Laboratory, Bar Harbor, ME
The studies of spontaneous mutations in mice have provided valuable disease models and important 
insights into the mechanisms of human disease. Here we report a new, recessive spontaneous mutant 
allele of the desmoplakin gene (Dsp) called ruffled (Dsprul). The rul allele arose in the RB156Bnr/
EiJ strain in 1989 and results in mice having an abnormal coat recognizable by 10 days of age. 
By way of High-Throughput Sequencing (HTS) we show that the Dsp gene has a small insertion 
at 38,288,978 bp of chromosome 13, which is predicted to result in a frameshift, truncating the 
c-terminal portion of DSP. The truncation of the DSP protein can be seen by Western blot. His-
tologically, mutant hair shafts demonstrate degenerative changes resulting in constriction of the 
shaft. In addition, widespread vibrissae follicular dystrophy is observed in muzzle of mutant mice. 
Lastly, reminiscent of the related Dsg4lah-J lesion, Dsprul mice exhibit swelling of the pelage hair 
fiber within the hair follicle. The Dsprul mouse will provide an invaluable model to investigate the 
pathogenesis of mutations in the adhesion molecules coded by the desmosomal genes. We report 
here the phenotype and molecular defect of this new spontaneous mutation.    
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A novel missense mutation in HOXC13 leads to pure hair and nail ectodermal dysplasia
DA Glass,1,2 NG Agim,1 JC Cohen2 and HH Hobbs2 1 Dermatology, UT Southwestern 
Medical Center, Dallas, TX and 2 Eugene McDermott Center for Human Growth and 
Development, UT Southwestern Medical Center, Dallas, TX
Pure hair and nail ectodermal dysplasia (PHNED) is a rare congenital condition characterized 
by hypotrichosis or complete alopecia, as well as nail dystrophy, without other ectodermal or 
nonectodermal manifestations. Mutations in two genes found on chromosome 12q, the type II hair 
keratin gene KRT85 and the HOXC13 homeobox gene, have recently been identified in families with 
autosomal recessive PHNED. Here, we report a consanguineous Hispanic family with an affected 
boy having complete alopecia and nail dystrophy since birth. Both his clinical findings and the 
family history were consistent with autosomal recessive PHNED. While investigation of the KRT85 
coding sequence detected no abnormalities, sequencing analysis of HOXC13 identified a novel 
homozygous missense mutation (c.A812G; p.Gln271Arg). The mutation lies within the DNA-binding 
domain of HOXC13 and is predicted to disrupt its DNA-binding ability. All previously reported 
cases of HOXC13-associated PHNED have been due to nonsense mutations or deletions; this is the 
first reported case of PHNED due to a missense mutation within HOXC13. This study illustrates the 
importance of the role HOXC13 plays in human hair and nail development.    
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Adipose-derived stem cells as a potential therapy for collagen VI-related congenital muscular 
dystrophy
V Alexeev, M Chu and O Igoucheva Dermatology and Cutaneous Biology, Thomas Jefferson 
University, Philadelphia, PA
Congenital muscular dystrophies (CMD) are a clinically and genetically heterogeneous group of neu-
romuscular disorders characterized by muscle weakness within the first two years of life. Collagen 
VI-related muscle disorders have recently emerged as one of the most common types of CMD. COL6 
CMD is caused by deficiency and/or dysfunction of extracellular matrix (ECM) protein collagen VI. 
Currently, there is no specific treatment for this disabling and life-threatening disease. The primary 
cellular targets for collagen VI CMD therapy are fibroblasts in muscle, tendon and skin, as opposed 
to muscle cells for other types of muscular dystrophies. Here, we developed a procedure for isolation 
of human stem cells from adipose layer of neonatal skin. The adipose-derived stem cells (ADSC) 
were examined for expression of extracellular matrix (ECM) and related genes using gene expression 
array analysis. The therapeutic potential of ADSC was assessed after a single intramuscular trans-
plantation in collagen VI-deficient mice. Analysis of primary cultures confirmed that established 
ADSC represent morphologically homogenous population with phenotypic and functional features 
of adult mesenchymal stem cells. A comprehensive gene expression analysis showed that ADSC 
express a vast array of ECM genes. Importantly, it was observed that ADSC synthesize and secrete 
all three collagen VI chains, suggesting suitability of ADSC for COL6 CMD treatment. Furthermore, 
we have found that a single intramuscular transplantation of ADSC into Col6a1-/-Rag1-/- mice under 
physiological and cardiotoxin-induced injury/regeneration conditions results in efficient engraftment 
and migration of stem cells within the skeletal muscle. Importantly, we showed that ADSC can 
survive long-term and continuously secrete the therapeutic collagen VI protein missing in the mutant 
mice. Overall, our findings suggest that stem cell therapy can potentially provide a new avenue for 
the treatment of COL6 CMD and other muscular disorders and injuries.    
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Ichthyosis with confetti mutant allele causes neonatal lethality in a murine model
Y Lu,1 H Mirza,2 R Hu,2 J Zhou,2 D Crumrine,3 P Elias,3 R Lifton1 and K Choate2 1 Genetics, 
Yale University School of Medicine, New Haven, CT, 2 Dermatology, Yale University 
School of Medicine, New Haven, CT and 3 Dermatology, University of California School of 
Medicine, San Francisco, CA
Ichthyosis with confetti (IWC) is a rare, severe skin dominant skin disorder caused by frame shift 
mutations in the non-helical tail domain of keratin 10 (KRT10). We generated a knock-in mouse 
model of IWC through homologous recombination at the murine KRT10 locus, introducing an allele 
with a frameshift mutation analogous to that seen in IWC patients. After confirming targeting, gener-
ation of chimeric mice, and breeding, we noted small litter sizes with 4-6 pups in the F1 generation 
in contrast to the typical litter size of 8-12. Timed breeding followed by Caesarian section at E20 
observed pup delivery both revealed normal litter size. After delivery, approximately 50% of pups 
were observed to die within 24 hours post-partum. These pups showed deep erythema and scaling 
and had no milk present in the stomach despite evidence of demonstrated ability to suckle and 
swallow. We assessed barrier acquisition pattern and defects at embryonic day 16 to birth via dye 
permeation finding no evidence of delay, defect, or aberrant patterning. Despite this, there was a 
marked increase in transepidermal water loss (0.9 g m-2 h-1+/+ vs 2.4 (g m-2 h-1 +/K10IWC, p< 10-07) 
via tewameter measurement. Ex-vivo epidermal dehydration assay also showed 46.85% ±6.58 
loss of total skin weight in K10IWC versus only 19.02%±5.52 in control skin over 24h. Histology of 
neonatal skin shows features of human IWC including acanthosis, perinuclear vacuolization, lack of 
a granular layer and parakeratosis. Immunolocalization of KRT10 shows diminished expression and 
nucleolar localization in terminally differentiated cells . Electron microscopy demonstrates reduced 
filament density and poor investment of desmosomes with keratin intermediate filaments. Altogether, 
these findings demonstrate that our murine model reproduces features of human IWC and have 
motivated generation of a conditional murine allele to study revertant mosaicism in this disorder.   
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Krt85whnl: A new spontaneous mouse mutation affecting nail growth and development
H Fairfield, P Ward-Bailey, JP Sundberg, C Potter and CH Pratt The Jackson Laboratory, Bar 
Harbor, ME
Laboratory mice and humans are remarkably similar at the basic genetic level, but more relevant, 
have nails that look different superficially but are very similar histologically. Numerous single gene 
mutations have been identified in mice that result in nail deformities. We identified a spontaneous, 
autosomal, recessive mutation called witch nails (whnl) in which the nail plate does not form prop-
erly. This mutation arose spontaneously in a production colony of MRL/MpJ-Faslpr/J at The Jackson 
Laboratory. Homozygous mutant mice are recognizable by 8 weeks of age by their long, curved 
nails. Heterozygotes have no noticeable phenotype. Using small sequence length polymorphism 
(SSLP) mapping, the whnl mutation mapped to a 4Mb interval on Chr. 15 between 98.7Mb and 
102.8Mb. A 7-bp insertion has been identified in the 3’ region of exon 9 in the 4732456N10Rik 
(Krt85) gene. This insertion is predicted to result in a frameshift that changes Serine 476 to Argi-
nine thereby introducing 36 novel amino acids into the protein before a premature stop codon (p. 
Ser476ArgfsTer36). This is the first spontaneous mutation affecting keratin 85 which provides new 
insight into the normal regulation of the molecular pathways of nail development.    
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Targeted resequencing of the costimulatory locus identifies all variants carried on GWAS 
defined risk haplotypes in alopecia areata
T Yamany, L Petukhova, E Drill, L Bian, JD Broadbent, P Nagy and A Christiano Columbia 
Univ, NY, NY
The costimulatory locus contains three key immunoregulatory genes (CD28, CTLA4, and ICOS), 
and was one of the first genomic regions associated with autoimmunity outside of the HLA locus. 
GWAS have provided robust agnostic evidence for association of this region with type 1 diabetes, 
rheumatoid arthritis, celiac disease, Graves disease and alopecia areata (AA). In our AA GWAS, we 
identified 8 typed and 59 imputed variants with statistically significant association, and conditional 
analysis on the typed SNPs identified two independent risk haplotypes at the locus. Despite the 
extensive evidence for conferring risk, the mechanisms by which genetic variants contribute to 
disease have remained elusive. In order to systematically identify all AA risk variants at this locus, 
here we performed targeted resequencing of the costimulatory locus in 122 AA patients from our 
GWAS cohort. We targeted a 297Kb region including all exons and introns of CD28, CTLA4, 
ICOS, as well as all intergenic and flanking regions, utilizing RainDance technology and next 
generation sequencing. This experiment identified 1209 variants that passed rigorous QC filters, 
which we computationally phased, allowing us to assign alleles to chromosomes. Among the 244 
sequenced chromosomes, we identified 88 that carried either one or both of the GWAS-identified 
risk haplotypes. We next identified 179 variants whose alleles are significantly enriched on the 
chromosomes carrying GWAS risk haplotypes (p<4.1e-5), 119 of which were not identified in our 
GWAS. Among these enriched SNPs, there is one CTLA4 protein coding variant (rs231775; p. T17A), 
three variants that had been reported in the literature to be CTLA4 eQTLs (rs231775, rs3087243, 
rs11571316), five SNPs annotated with regulatory functions in encode, and 20 SNPs reported to fall 
within transcription factor binding sites. Targeted deep resequencing of GWAS loci has allowed us 
to fully enumerate all variants carried on the GWAS risk haplotypes, allowing us to move forward 
in identifying genetic contributions to complex disease.    
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Genome-wide serum miRNA expression profiles identify serum miRNAs as potential bio-
markers for human psoriatic arthritis
L Han,1,2 M Weiland,1 C Yin,1 C Lu,2 RP Nair,3 L Zhou,1,4 HW Lim,1 JT Elder3 and Q Mi1,4 
1 Dermatology and Immunology Program, Henry Ford Health System, Detroit, MI, 2 
Dermatology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, China, 
3 Dermatology, University of Michigan Medical School, Ann Arbor, MI and 4 Internal 
Medicine, Henry Ford Health System, Detroit, MI
Approximately 20-30% of patients with cutaneous psoriasis (PsC) develop psoriatic arthritis (PsA). 
Early diagnosis and intervention are keys to prevent permanent joint deformation. However, no 
standardized method exists for early detection of PsA. Thus, there is an urgent need to develop 
assays which can predict PsA development. Non-protein coding small RNAs, microRNAs (miRNAs) 
control a wide range of biological processes. Several lines of evidence indicate that miRNAs are 
involved in the pathogenesis of psoriasis. We have recently identified distinct miRNAs in the serum 
of patients suffering from autoimmune and neoplastic diseases, and shown that serum miRNAs 
could serve as disease prediction biomarkers. We hypothesized that the differential expression 
of serum specific miRNAs reflects key biological events that differentiate the pathogenesis of PsC 
and PsA and can serve as predictive and diagnostic biomarkers for PsA in psoriatic individuals. 
To test this hypothesis, serum miRNA expression profiles from 23 PsA patients, 23 age-, sex-, and 
PASI-matched PsC patients, and 23 age- and sex-matched healthy controls (HC) were investigated 
using TaqMan real-time RT-PCR MicroRNA Arrays and analyzed with RealTime Statminer software. 
487 serum miRNAs were detected in the combined samples, and 45 of them were differentially 
expressed in PsC and PsA patients compared to HC (Limma T test p<0.05, Benjamini-Hochberg 
FDR<0.2). Eighteen miRNAs were first selected for further validation by single TaqMan RT-PCR, 
and 12 of them were validated. Six miRNAs were significantly changed in PsA group compared 
to PsC and HC. Our study suggests that serum miRNAs may serve as novel promising biomarkers 
for PsA prediction, diagnosis and progression, and may also facilitate the development of new 
intervention strategies for PsA therapy.    
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Analysis of CARD14 polymorphisms in pityriasis rubra pilaris: Activation of NF-κB
Q Li,1 HJ Chung,1 J Andrews,1 H Sabaawy,2 E Sprecher3 and J Uitto1 1 Jefferson Medical 
College, Philadelphia, PA, 2 Rutgers-Cancer Institute, New Brunswick, NJ and 3 Tel Aviv 
Sourasky Medical Center, Tel Aviv, Israel
Pityriasis rubra pilaris (PRP), a papulo-squamous inflammatory skin disorder, is in most cases spo-
radic, but a familial form, <6% of cases, with autosomal dominant inheritance with partial pen-
etrance has been reported. We recently demonstrated that patients with the familial form of PRP 
harbor gain-of-function mutations in the CARD14 gene, an activator of nuclear factor κB (NF-κB). In 
this study we investigated whether mutations in this gene might also underlie cases of sporadic PRP. 
In these patients, immunohistochemistry of epidermis in lesional skin showed evidence of NF-κB 
activation. DNA was obtained from 46 PRP patients with no family history. DNA from all patients 
was used for amplification of exons 3 and 4 of CARD14 which harbor mutations in the familial form 
of PRP. The remaining 18 exons were analyzed in a subset of 20 patients with definitive diagnosis of 
PRP, based on clinical information and histopathology. Among the 16 sequence variants detected, 4 
were considered potentially pathogenic based on functional prediction program analysis, presence 
in the SNP database at frequency of <1%, and conservation of the mutated amino acid in CARD14 
through evolution. To examine the consequences of these mutations on the activation of NF-κB, 
independent in vitro and in vivo assays were performed, in vitro in transgenic HeLa cells constitu-
tively expressing low levels of luciferase reporter under a NF-κB responsive element, and in vivo 
assaying, a novel transgenic zebrafish strain which endogenously expresses an NF-κB responsive 
element linked to a GFP reporter. These approaches indicated that CARD14 mutations in a limited 
number of patients with sporadic PRP could activate NF-κB. Thus, while NF-κB activation may be 
a common mechanism in familial PRP, CARD14 mutations are present, yet rare, in sporadic cases.   
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Genome-wide target gene analysis reveals both cell autonomous and paracrine effects of 
JunB in epidermal growth and inflammation
X Zhang,1 J Wu,1 J Jin,1 X Qin,2 O Fedrigo2 and JY Zhang1 1 Dermatology, Duke University 
School of Medicine, Durham, NC and 2 Duke University Genome Science and Policy, 
Durham, NC
JunB, an AP-1 family transcriptional factor, plays important roles in tissue homeostasis of various 
organs including skin. We and others have previously demonstrated JunB suppresses epidermal 
growth, inflammation and neoplasia. To explore the mechanisms underlying JunB function, we 
first performed genome-wide target gene analysis using ChIP-seq. A total number of 2377 target 
genes were identified and about 43% of them were located within promoter or distal regions of 
protein-coding genes, long non-coding RNAs and miRNAs. Pathway analysis based on promoter 
and distal region revealed the interactions of JunB with genes involved in multiple cellular signaling 
pathways, such as p53 pathway (CDKN1A, TNFRSF10C and SERPINE1), MAPK pathway (DUSP7), 
and NF-KB pathway (STK40 and IKBα). To determine the importance of protein-DNA interaction, 
we performed siRNA mediated gene silencing of JunB followed by RNA-seq analysis. We found 
that reduced JunB expression resulted in upregulation of 452 genes and downregulation of 868 
genes. In particular, JunB downregulated NF-KB pathway negative regulators STK40 and IKBα and 
upregulated cytokines such as TNF and IL8, all of which were identified as JunB targets by Chip-seq. 
Taken together, our findings indicate that JunB is involved in regulating a wide array of target genes, 
and suggest that JunB controls epidermal growth and inflammation through both cell autonomous 
and paracrine effects. Currently, our efforts are focused on determining the functional importance 
of JunB regulation of select target genes through both in vitro and in vivo studies.    
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Somatic activating mutations in HRAS and NRAS cause cutaneous skeletal hypophospha-
temic syndrome
YH Lim,1 D Ovejero,2 J Sugarman,3 L Eichenfield,4 M Levy,5 M Collins2 and KA Choate1 1 
Dermatology and Pathology, Yale School of Medicine, New Haven, CT, 2 Craniofacial and 
Skeletal Disease Branch, NIDCR, NIH, Bethesda, MD, 3 Dermatology, UCSF, San Francisco, 
CA, 4 Dermatology, UCSD, San Diego, CA and 5 Dermatology, Dell Children’s Medical 
Center, Austin, TX
Fibroblast growth factor-23 (FGF23) is a bone-derived hormone that regulates phosphorus homeosta-
sis. Pathologically elevated levels of FGF23 result in renal phosphate wasting, leading to childhood 
rickets and osteomalacia. In cutaneous skeletal hypophosphatemic syndrome (CSHS), elevated 
serum FGF23 levels are found in association with foci of dysplastic bone and mosaic cutaneous 
disorders that affect large proportions of the skin, such as epidermal nevi (EN) and giant congenital 
melanocytic nevi (GCMN). However, the cause and source of elevated serum FGF23 is unknown. 
Further, the skin and bone lesions are variably associated with other abnormalities in the eye, brain 
and vasculature; the wide distribution of involved tissues and the appearance of multiple segmental 
skin and bone lesions suggest that these conditions result from early embryonic somatic mutations. 
We report five cases of CSHS, four with large EN and one with GCMN. Exome sequencing of 
blood and affected skin tissue identified somatic activating mutations of HRAS or NRAS in each 
case without recurrent secondary mutation, and we further found that the same mutation is present 
in dysplastic bone. The discovery of somatic activating RAS mutation in bone, the endogenous 
source of FGF23, provides the first evidence that elevated serum FGF23 levels, hypophosphatemia 
and osteomalacia in CSHS are associated with pathologic Ras activation. Furthermore, we report a 
case of CSHS without a mutation in RAS, suggesting this disease may result from mutation in other 
genes. Our findings provide insight in the heretofore limited understanding of FGF23 regulation 
and highlight the pleiotropic action of RAS mutation in the skin and bone.    
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AP1 factors are required for normal embryonic skin development and absence of expression 
produces a collodion baby disease phenotype
C Young,1 W Xu,1 R Eckert1,2 and E Rorke3 1 Biochemistry & Molecular Biology, University 
of Maryland School of Medicine, Baltimore, MD, 2 Dermatology, University of Maryland 
School of Medicine, Baltimore, MD and 3 Microbiology & Immunology, University of 
Maryland School of Medicine, Baltimore, MD
The activator protein one (AP1) transcription factors are key controllers of epidermal keratinocyte 
proliferation, differentiation, apoptosis and transformation. We recently developed a mouse model 
of reduced suprabasal epidermal AP1 factor function that faithfully mimics human loricrin kerato-
derma. Keratoderma is a human skin disease marked by epidermal hyperproliferation, hyperkerato-
sis, parakeratosis, attenuated differentiation, autoamputation of the digits, and nuclear localization 
of loricrin. Our findings provide the first evidence that reduced activity in a specific signaling 
cascade in a specific epidermal layer can trigger keratoderma. We now examine the impact of AP1 
factor inhibition in embryonic epidermis. We hypothesized that compromising AP1 transcription 
factor function during embryogenesis may reproduce the collodion phenotype observed in human 
babies predisposed to develop keratoderma. Creating a model is important, as thirty-seven percent 
of human loricrin keratoderma patients are born as collodion babies (i.e., encased in a shiny, taut, 
parchment-like membrane). These newborns have defective epidermal barrier function and must 
receive intensive assistance in order to survive. We studied AP1 factor inactivation at embryonic 
days E14, E16 and E18 and examined gross morphology, epidermal histology, cornification, and 
impact on epidermal barrier function. The findings indicate that inactivation of epidermal AP1 
factor function in embryos produces a collodion phenotype, impairs barrier function and causes 
death within 24 h after birth. These interesting findings indicate that epidermal AP1 transcription 
factor activity is essential for normal embryonic epidermal development and that perturbing AP1 
factor function during embryogenesis leads to a disease state that mimics human keratoderma.   
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Suppressing AP1 factor signaling in suprabasal epidermis produces a keratoderma phenotype
E Rorke,3 G Adhikary,1 C Young,1 D Roop4 and R Eckert1,2 1 Biochemistry & Molecular 
Biology, University of Maryland School of Medicine, Baltimore, MD, 2 Dermatology, 
University of Maryland School of Medicine, Baltimore, MD, 3 Microbiology & Immunology, 
University of Maryland School of Medicine, Baltimore, MD and 4 Dermatology, University 
of Colorado, Aurora, CO
Keratodermas comprise a heterogeneous group of highly debilitating and painful disorders char-
acterized by thickening of the skin with marked hyperkeratosis. Some of these diseases are caused 
by genetic mutation, while other forms are acquired in response to environmental factors. Our 
understanding of signaling changes that underlie these diseases is extremely limited. In the present 
study we describe a keratoderma phenotype in mice in response to suprabasal epidermis-specific 
inhibition of activator protein 1 transcription factor signaling. These mice develop a severe phe-
notype characterized by hyperplasia, hyperkeratosis, parakeratosis and impaired epidermal barrier 
function. The skin is scaled, constricting bands encircle the tail and digits, the footpads are thickened 
and scaled, and loricrin staining is markedly reduced in the cornified layers and increased in the 
nucleus. Some features of this phenotype, including nuclear loricrin localization and pseudoainhum 
(autoamputation) are characteristic of Vohwinkel Syndrome. Our findings suggest that suppression of 
AP1 factor signaling in the suprabasal epidermis is a key event in the pathogenesis of keratoderma. 
We confirm that the phenotype develops in a loricrin null genetic background, indicating that 
suppressed suprabasal AP1 factor function is sufficient to drive this disease. We also show that the 
phenotype regresses when suprabasal AP1 factor signaling is restored. These studies provide a first 
glimpse that absence of activity of a specific transcription factor family may cause keratoderma.   
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Identification of novel and common regulatory variants in an adult atopic dermatitis cohort 
with baseline skin defects
T Pansuriya,1 KJ Gulewicz,1 A Shemer,2 W Jones,1 A Quiggle,1 Z Goodwin,1 J Krueger,3 
E Guttman4 and C de Guzman Strong1 1 Washington Univ. SOM, St. Louis, MO, 2 Tel-Aviv 
Univ., Tel Aviv, Israel, 3 Rockefeller Univ., New York, NY and 4 Icahn SOM, Mt. Sinai, 
New York, NY
Atopic Dermatitis (AD) is a common inflammatory skin disease with strong heritability. Although 
up to 50% of moderate to severe AD is associated with mutations in the skin barrier gene filaggrin 
(FLG), other genomic regions (1q and 11q) have been implicated. Overall, the disease variants in 1q 
and 11q are unknown. Motivated by recent studies identifying enrichment for noncoding regulatory 
variation in common disease, we performed targeted next-generation sequencing (NGS) to discover 
and characterize regulatory variants in 1q and 11q in an adult cohort with a well-characterized 
moderate to severe AD phenotype. This AD cohort is distinguished by baseline skin barrier impair-
ment owing to downregulation of Epidermal Differentiation Complex (EDC) genes and immune 
abnormalities and the presence of fewer FLG intragenic copy number repeats in AD patients vs. 
controls (Wilcoxon test, p=0.018). We hypothesized additional variants in regulatory elements 
that are in linkage disequilibrium with FLG (rs877776, chr 1q21) or GWAS SNP (rs7927894, 
chr 11q13) to explain the predisposed baseline skin defects and hence persistence of AD and in 
this adult cohort. Targeted NGS of 5 ENCODE-annotated enhancers and 4 functional regulatory 
elements (REs) surrounding said SNPs in our pooled AD cohort identified 18 regulatory variants, 
including 16 common SNPs. Two variants (REs 180 and 184 in the EDC) were novel (absent in 
1000 Genomes, dbSNP135) and were genotyped in 2 individual patients. Cell-based reporter assays 
revealed significant differences in regulatory activities for the minor novel variants and not in the 
minor common variants in comparison to the respective major allele variants. Thus, our novel 
approach using targeted NGS in a clinically distinct cohort increases our understanding of the 
genetic architecture of AD by identifying for the first time the association and effect of functional 
novel regulatory variants in AD.    
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Genetic variants in the moyamoya susceptibility gene, RNF213, in PHACE syndrome
D Siegel,1,2 M Maheshawri,2,3 BA Drolet1,2 and EA Worthey2,4 1 Dermatology, Medical 
College of Wisconsin, Milwaukee, WI, 2 Pediatrics, Medical College of Wisconsin, 
Milwaukee, WI, 3 Radiology, Medical College of Wisconsin, Milwaukee, WI and 4 Human 
and Molecular Genetics, Medical College of Wisconsin, Milwaukee, WI
Genetic variants in the RNF213 gene have been reported in association with both intracranial major 
artery stenosis/occlusion and moyamoya disease, mainly in the East Asian populations. PHACE 
syndrome is an acronym for posterior fossa malformation, hemangioma, arterial anomalies, cardiac 
anomalies/coarctation of the aorta and eye anomalies. Through the PHACE Syndrome International 
Clinical Registry and Genetic Repository, we have performed whole exome sequencing on 15 
patients. We report a patient with PHACE syndrome and moyamoya disease with a compound 
heterozygous variant in RNF213. This patient had a large segmental hemangioma, progressive 
cervical and cerebral arterial anomalies with moyamoya collaterals in the region of the left middle 
cerebral artery and posterior communicating artery territories. The patient subsequently underwent 
neurosurgical revascularization and is currently stable. In an initial screen of whole exome sequenc-
ing results on these 15 patients, 3 additional patients had compound heterozygous variants and 2 
had a heterozygous variant in RNF213. We are currently investigating variants in RNF213 in the 
larger PHACE syndrome cohort through targeted next generation sequencing and in silico modeling.   
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Disorders of keratinization: Genetic characterization of a large cohort via targeted and 
whole exome sequencing
LM Boyden,1 BG Craiglow,2 R Hu,2 J Zhou,2 E Loring,1 L Milstone,2 RP Lifton,1 AS Paller3 
and KA Choate2 1 Genetics, Yale University School of Medicine, New Haven, CT, 2 
Dermatology, Yale University School of Medicine, New Haven, CT and 3 Dermatology, 
Northwestern University Feinberg School of Medicine, Chicago, IL
Primary disorders of keratinization (DOK) are generalized or localized skin diseases characterized 
by scaling and frequently associated additional epidermal and systemic sequelae. There is sub-
stantial heterogeneity, with inherited, sporadic, and somatic forms of varying severity. Over 50 
DOK genes have been identified, yet mutations in these genes explain only a portion of observed 
phenotypes. We have recruited a cohort of over 375 comprehensively phenotyped DOK kindreds 
and are employing a tiered approach whereby cases are screened for mutations in commonly 
causative genes, followed by whole exome sequencing to identify mutations in other known DOK 
genes and for novel gene discovery. Strategies include sequencing of parent-child trios to identify 
de novo mutations, and sequencing of paired genomic and affected tissue DNA samples when 
somatic mosaicism is suspected. To date, pre-screening for mutations by Sanger sequencing and 
targeted high-throughput sequencing has identified mutations in 150 DOK cases in 14 genes. Whole 
exome sequencing of remaining cases has revealed 66 with mutations in 32 DOK genes. Dominant, 
semi-dominant, recessive and X-linked inheritance patterns have been observed. Somatic mutations 
have been discovered in 7 cases; these range from localized to widespread mosaicism, and include 
genes in which somatic mutation has not been previously reported. Several genes are currently 
under investigation as potential novel causes of DOK, and recruitment of new kindreds is ongoing.   
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Whole exome sequencing powered genetic discovery in mosaic disease
JL Levinsohn,1 JM Teng,2 B Craiglow,1 T Burrow,3 J McNiff,1,4 A Lucky,5 R Antaya1 and 
K Choate1,4 1 Dermatology, Yale University, New Haven, CT, 2 Dermatology and Pediatrics, 
Stanford University, Stanford, CA, 3 Pediatrics, Cincinnati Children’s Hospital Medical 
Center, Cincinnati, OH, 4 Pathology, Yale University, New Haven, CT and 5 Pediatric 
Dermatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
Next generation sequencing has enabled discovery of causative somatic mutations in mosaic 
disorders which were previously intractable to investigation using classical genetic approaches. 
Keratinocytic mosaic disorders typically appear along lines of Blaschko representing patterns of 
ectodermal precursor migration. We employed paired whole-exome sequencing of affected tissue 
and blood, to identify the genetic basis of woolly hair with epidermal nevi (WHN) and porokera-
totic eccrine ostial dermal duct nevus (PEODDN). In each disorder, exome sequencing permitted 
a priori discovery of somatic mutations. As suggested in earlier work (Easton et al., 2012), exome 
sequencing in our case revealed a somatic p.G45E mutation in PEODDN tissue. In two WHN 
cases, we identified somatic HRAS p.G12S mutations present only within epidermal nevi and 
hair bulbs of woolly, but not straight hair. We and others have shown that RAS mutations also 
cause nevus sebaceus which is characterized by alopecia and sebaceous hyperplasia. While direct 
comparison of p.G12S to p.G13R mutation found in NS has not been performed, HRAS codon 12 
serine substitutions have been shown to be less activating than arginine, aspartic acid or valine 
substitutions (Malumbres and Barbacid, 2003). We propose that strongly activating RAS mutations 
cause hair follicle progenitors to undergo sebocyte differentiation resulting in NS phenotypes while 
weakly activating mutations cause a milder phenotype with abnormal curly hair but no sebaceous 
hyperplasia. Somatic mutation causes a spectrum of cutaneous phenotypes and we anticipate 
exome sequencing approaches in mosaic disorders will permit discoveries which will inform our 
understanding of cutaneous disease pathobiology.    
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Site-specific genome editing using TALENs for correction of dominant dystrophic epider-
molysis bullosa
S Shinkuma1 and A Christiano1,2 1 Dermatology, Columbia University, New York, NY and 2 
Genetics and Development, Columbia University, New York, NY
Genome editing with engineered site-specific endonucleases has recently emerged as a new 
approach to correct genetic mutations. One approach is homologous recombination with a DNA 
repair template to replace a mutant allele with a wild type sequence. A second approach involves 
non-homologous end joining leading to reading frame disruption and generation of a null allele, 
leading to hemizygosity. The latter approach is particularly applicable to dominantly inherited 
disorders caused by a dominant-negative mutation, which can be treated simply by knockout of 
the mutant allele, while leaving the wild type allele intact. In this study, we applied such a strategy 
to dominant dystrophic epidermolysis bullosa (DDEB) caused by a dominant negative mutation in 
COL7A1 gene encoding type VII collagen. We developed genome editing with transcription acti-
vator-like effector nucleases (TALENs) targeting the mutant site-specific sequence, 8068del17insGA 
in exon 109. Using the TAL Effector Nucleotide Targeter, several TALENs were designed to target 
the mutation site. To evaluate TALEN-mediated genetic disruption by non-homologous end join-
ing, we generated HEK293T cells transfected with partial COL7A1 gene with 8068del17insGA. 
The left and right TALENs were transfected and genomic DNA was assessed for modification by 
the Surveyor assay, which showed the activity of TALENs. TA cloning and Sanger sequencing 
confirmed the presence of several different out-of-frame deletions by non-homologous end joining, 
indicative of successful creation of a null allele. The potential for generating patient-specific fibro-
blasts or keratinocytes treated with TALENs could provide a significant benefit for DDEB patients 
in combination with induced pluripotent stem cell technologies. Our data establish the feasibility 
of site-specific genome editing to generate null alleles using TALENs targeting the mutation site in 
dominant negative disorders.    
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Gene expression profiling in pachyonychia congenita skin
Y Cao,1 RP Hickerson,1 M Mayer,2 B Seegmiller,1 M Flores,1 M Low,1 T Speaker,1 
A Vermeulen,2 D Leake,2 M Schwartz,3 L Milstone4 and R Kaspar1 1 TransDerm, Inc., Santa 
Cruz, CA, 2 Thermo Fisher Scientific, Lafayette, CO, 3 Pachyonychia Congenita Project, Salt 
Lake City, UT and 4 Department of Dermatology, Yale University, New Haven, CT
Pachyonychia congenita (PC) is a skin disorder resulting from mutations in the KRT6A, KRT6B, 
KRT6C, KRT16, and KRT17 genes. One of the major symptoms is painful plantar keratoderma, which 
negatively impacts quality of life. The pathogenic sequalae resulting from the keratin mutations, 
including intense pain, remain unclear. To better understand PC pathogenesis at the molecular level, 
RNA profiling was performed on biopsies taken from both PC-involved and uninvolved plantar 
skin of PC patients as well as from plantar skin of control volunteers. 112 differentially-expressed 
genes common to both K6 and K16 patient groups were identified in PC-involved skin biopsies 
compared to adjacent uninvolved plantar skin using the criteria of statistical significance of p-value 
≤ 0.1 and fold-change ≥3.5. Among them, 25 encode structural proteins including keratins, small 
proline-rich and late cornified envelope proteins; 20 are related to metabolism; and 16 encode 
proteases, peptidases, and their inhibitors including kallikrein-related peptidases (KLKs) and serine 
protease inhibitors (SERPINs). Genes were also identified to be differentially-expressed only in 
K6 (81) or K16 (141) patients. Furthermore, 13 genes, which may be involved in nociception and 
neuropathy, were also identified using a slightly different fold-change cut-off (≥ 2.0). Many of these 
genes are involved in the pathways critical for the skin integrity, including keratinocyte proliferation 
and differentiation, cornification, and desquamation. 18 microRNAs were also identified to be 
differentially-expressed in PC-involved skin, some of which were altered by more than 20-fold. 
The RNA profiling data provide a foundation for unraveling the pathogenesis of PC and identifying 
targets for developing effective PC therapeutics.    
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APCDD1 is a novel dual WNT/BMP inhibitor in the skin and the developing nervous system 
and coordinates activation of WNT and BMP signaling pathways
V Luria,1,2 A Vonica,3 N Bhat,4 K Phan,5 L Iancu,6 A O’Donnell,2 B Riley,4 S Butler5 and 
A Christiano1 1 Columbia University Medical School, New York, NY, 2 Harvard Medical 
School, Boston, MA, 3 University of Rochester Medical Center, Rochester, NY, 4 Texas A&M 
University, College Station, TX, 5 University of California Los Angeles, Los Angeles, CA and 
6 Universität Stuttgart, Stuttgart, Germany
APCDD1 is a recently discovered gene that encodes a protein of unknown structure, is expressed in 
vertebrate animals during development and postnatally, is over-expressed in human colon cancers 
and mutated in Hereditary Hypotrichosis Simplex, a skin and hair disease. We previously showed 
that APCCD1 is a novel transmembrane protein that inhibits WNT signaling in skin and neurons 
(Shimomura et al., Nature 2010). Here we show APCDD1 is a potent inhibitor of BMP signaling in 
biochemical, cellular, embryological experimental and postnatal systems. Our functional studies 
show that APCDD1 inhibits BMP signaling in a cell-autonomous manner and functions upstream of 
Smad1, the main effector of BMP signaling. We show that early in development APCDD1 inhibits 
Bmp-dependent processes in frog and zebrafish, and that later in development it interferes with 
spinal cord interneuron BMP-dependent cell specification and axon pathfinding in chick. We show 
the molecular mechanism of these effects consists of APCDD1 binding of BMP pathway components 
and blocking the phosphorylation and nuclear translocation of Smad1. Using single-cell imaging and 
mathematical modeling, we show that the position of APCDD1 as a shared inhibitor of both BMP and 
WNT pathways, yet induced by WNT alone, enables it to function as a pathway intersection that may 
coordinate time-dependent dynamics of BMP and WNT outputs. Thus we have shown that APCDD1 
is a novel, dual WNT/BMP inhibitor that interferes with and coordinates the dynamic properties of 
two major signaling pathways central to vertebrate embryonic development and human disease.   
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Genetic epidemiology analysis of primary hyperhidrosis
G Zhang, Y Huang, M Su and Y Zhou Dermatology and Skin Science, University of British 
Columbia, Vancouver, BC, Canada
Primary hyperhidrosis is a common troubling condition that affects about 2.8% of the general 
population. The pathogenesis is unclear. Frequent occurrence of familial clustering in patients 
affected by this condition suggest a strong genetic predisposition in hyperhidrosis development. 
while the most commonly quoted model of genetic is autosomal dominant in nature, a detailed 
and systematic genetic model analysis has not been undertaken. The purpose of this study is to 
determine the genetic model for hyperhidrosis inheritance. To accomplish this goal, the Vancouver 
Hyperhidrosis Registry and Biobank has been established since 2003. Of the 1150 consecutive 
hyperhidrosis patients enrolled, 49% of the subjects had at least one additional first degree relative 
affected with the same condition. Detailed pedigree analysis revealed most pedigrees were com-
patible with autosomal dominant inheritance, some pedigrees had skip generations, and some were 
compatible with autosomal recessive inheritance. In the classic autosomal dominant pedigrees, 
genome wide linkage analysis revealed significant linkage to multiple chromosomal loci, suggesting 
multiple genes are involved in hyperhidrosis pathogenesis. In conclusion, this study showed that the 
genetic pattern of hyperhidrosis is complex and multiple genes are likely involved. Further studies 
are warranted to uncover these genes.    
      
      
